Processing 00000000.tx.1: Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF) Ming-Tat Ling, Tracy C.M. 

Phrase: "Overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in prostate cancer cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "angiogenesis through the activation of vascular endothelial growth factor (VEGF) Ming-Tat Ling,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0312818:Angiogenesis growth factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C2249517:activation of angiogenesis [Organism Function]
   751   C0002976:Angiogenesis Factor [Biologically Active Substance]
   736   C0302600:Angiogenesis [Organ or Tissue Function]
   736   C1519670:angiogenesis [Neoplastic Process]

Phrase: "Tracy C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Lau, Chun Zhou, Chee Wai Chua, Wai Kei Kwok, Qi Wang, Xianghong Wang* and Yong-Chuan Wong* Cancer Biology Group, Department of Anatomy, Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong, SAR, China * To whom correspondence should be addressed at: Department of Anatomy, Laboratory Block, Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong, SAR, China. 

Phrase: "Lau,"

Phrase: "Chun Zhou,"

Phrase: "Chee Wai Chua,"

Phrase: "Wai Kei Kwok,"

Phrase: "Qi Wang,"

Phrase: "Xianghong Wang"

Phrase: "*"

Phrase: "and"

Phrase: "Yong-Chuan Wong"

Phrase: "* Cancer Biology Group,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C1516164:Cancer Biology [Biomedical Occupation or Discipline]

Phrase: "Department of Anatomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "The University of Hong Kong,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:Hong Kong [Geographic Area]
   861   C2987742:Hong Kong [Fish]
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "21 Sassoon Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "Hong Kong,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019907:Hong Kong [Geographic Area]
  1000   C2987742:Hong Kong [Fish]

Phrase: "SAR,"

Phrase: "China"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008115:China [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Anatomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Laboratory Block,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "The University of Hong Kong,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:Hong Kong [Geographic Area]
   861   C2987742:Hong Kong [Fish]
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "21 Sassoon Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "Hong Kong,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019907:Hong Kong [Geographic Area]
  1000   C2987742:Hong Kong [Fish]

Phrase: "SAR,"

Phrase: "China."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008115:China [Geographic Area]
Processing 00000000.tx.3: Tel: +852 2819 9226; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+852 2819 9226"

Phrase: ";"
Processing 00000000.tx.4: Fax: +852 2817 0857; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+852 2817 0857"

Phrase: ";"
Processing 00000000.tx.5: Email: ycwong{at}hkucc.hku.hk or xhwang{at}hkucc.hku.hk  Abstract Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Androgen-independent metastatic prostate cancer is the main cause of cancer related death in men. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "ycwong{at}hkucc.hku.hk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0019907:HK [Geographic Area]
   804   C2681927:HK [Gene or Genome]
   804   C2987742:HK [Fish]

Phrase: "or"

Phrase: "xhwang{at}hkucc.hku.hk  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Androgen-independent metastatic prostate cancer"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   924   C1654637:androgen independent prostate cancer [Neoplastic Process]
   884   C0936223:Metastatic Prostate Cancer [Neoplastic Process]
   853   C0027627:metastatic cancer [Neoplastic Process]
   853   C0346957:metastatic cancer [Neoplastic Process]
   853   C2939419:Metastatic cancer [Neoplastic Process]
   853   C2939420:metastatic cancer [Neoplastic Process]
   840   C0376358:Prostate Cancer [Neoplastic Process]
   840   C0600139:Prostate Cancer [Neoplastic Process]
   840   C2984325:Prostate cancer [Functional Concept]
   840   C3541264:Prostate Cancer [Intellectual Product]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0033572:Prostate [Body Part, Organ, or Organ Component]
   804   C0998265:Cancer [Eukaryote]
   804   C1278980:Prostate [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]

Phrase: "is"

Phrase: "the main cause of cancer related death"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0007465:Cause of Death [Finding]
           Death Cause
   804   C0804771:Cause of death [Clinical Attribute]
   774   C1516195:Cancer Cause [Biomedical Occupation or Discipline]
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "in men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.6: One of the reasons for this is the lack of understanding of the molecular mechanisms leading to the metastatic progression of prostate cancer. 

Phrase: "One of the reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "for this"

Phrase: "is"

Phrase: "the lack of understanding of the molecular mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "leading to the metastatic progression of prostate cancer."
Meta Candidates (Total=31; Excluded=4; Pruned=0; Remaining=27)
   812   C0376358:Cancer of the Prostate [Neoplastic Process]
           Cancer of Prostate
           Prostate Cancer
   812   C0600139:Cancer of the Prostate [Neoplastic Process]
           Cancer of Prostate
           Prostate Cancer
   793   C0936223:Metastatic Prostate Cancer [Neoplastic Process]
   770   C2984325:Prostate cancer [Functional Concept]
   770   C3541264:Prostate Cancer [Intellectual Product]
   767   C0027627:metastatic cancer [Neoplastic Process]
   767   C0036525:Metastatic to [Functional Concept]
           Metastatic
   767   C0178874:cancer progression [Neoplastic Process]
   767   C0346957:metastatic cancer [Neoplastic Process]
   767   C1947901:Cancer Progression [Pathologic Function]
   767   C2939419:Metastatic cancer [Neoplastic Process]
   767   C2939420:metastatic cancer [Neoplastic Process]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0033572:Prostate [Body Part, Organ, or Organ Component]
   744   C0242656:progression [Pathologic Function]
   744   C0332152:Leading [Temporal Concept]
   744   C0449258:Progression [Functional Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1278980:Prostate [Body Part, Organ, or Organ Component]
   744   C1306459:Cancer [Finding]
   744   C1522484:metastatic [Quantitative Concept]
   744   C1522538:Leading [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: In this study, we have demonstrated that overexpression of Id-1 (inhibitor of differentiation/DNA synthesis), a member of the helixloophelix family proteins, is a key factor in promoting angiogenesis through activation of the vascular endothelial growth factor (VEGF) in prostate cancer cells. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "(inhibitor of differentiation/DNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a member of the helixloophelix family proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "is"

Phrase: "a key factor in promoting angiogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0002976:Angiogenesis Factor [Biologically Active Substance]
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "through activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the vascular endothelial growth factor"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ")"

Phrase: "in prostate cancer cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]
Processing 00000000.tx.8: Using prostate cancer cells ectopically transfected with the Id-1 gene, we found that upregulation of Id-1 induced VEGF secretion through activation of the VEGF gene transcription. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "prostate cancer cells ectopically"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0334227:cancer cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the Id-1 gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0309276:ID-1 [Pharmacologic Substance]
   783   C1706509:Gene ID [Intellectual Product]
   753   C0017337:Gene [Gene or Genome]
   753   C0600091:ID [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that upregulation of Id-1 induced VEGF secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   772   C1160196:up-regulation of growth [Organism Function]
   772   C1523072:up-regulation of secretion [Cell Function]
   738   C0041904:Up-Regulation [Cell Function,Molecular Function]
   738   C0162493:Up-Regulation [Genetic Function]

Phrase: "through activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the VEGF gene transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040649:Gene Transcription [Genetic Function]
           Transcription
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.9: Downregulation of Id-1, however, led to the suppression of VEGF secretion and its gene promoter activity. 

Phrase: "Downregulation of Id-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "however,"

Phrase: "led to the suppression of VEGF secretion"
Meta Candidates (Total=28; Excluded=5; Pruned=0; Remaining=23)
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   757   C0151686:Growth suppression [Pathologic Function]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0220844:growth [Physiologic Function]
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]
   739   C1521761:Factor [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1708698:LED [Manufactured Object]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   724   C0014261:Endothelium, Vascular [Tissue]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its gene promoter activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.10: The association between Id-1 and VEGF was also confirmed on human xenografts by immunohistochemical staining. 

Phrase: "The association between Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "was"

Phrase: "also"

Phrase: "confirmed on human xenografts"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0086418:Human [Human]
   770   C0520484:xenografts [Therapeutic or Preventive Procedure]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0522537:Xenografts [Biomedical or Dental Material]
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "by immunohistochemical staining."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.11: In addition, the growth medium generated by the Id-1 expressing cells was able to promote morphological changes as well as capillary tube formation in human umbilical vein endothelial cells (HUVECs) at similar degrees to the recombinant human VEGF. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]

Phrase: "generated by the Id-1 expressing cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C0600091:ID [Intellectual Product]
   748   C3146294:Generated [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "morphological changes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   933   C1260954:Morphologic change [Anatomical Abnormality]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0543482:morphological [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0332437:Morphology [Qualitative Concept]
   789 E C0700329:Morphology, NOS [Finding]
   789 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "as well as"

Phrase: "capillary tube formation in human umbilical vein endothelial cells (HUVECs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C2752214:tube formation [Organ or Tissue Function]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "at similar degrees"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0449286:degrees [Quantitative Concept]
   861   C0542560:degrees [Intellectual Product]
   827 E C0441889:Degree [Qualitative Concept]
   827 E C1561545:degree [Quantitative Concept]
   827 E C2348088:Degree [Quantitative Concept]

Phrase: "to the recombinant human VEGF."
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   947   C1171892:vascular endothelial growth factor, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   941   C1522575:Recombinant Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Vascular Endothelial Growth Factor
   904   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0014257:Endothelial [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C1801960:Vascular [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   791   C0014261:Endothelium, Vascular [Tissue]
   763 E C1706972:Blood Vessel Endothelium [Tissue]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.12: Furthermore, inhibition of VEGF function by the treatment with an Flk-1 inhibitor, SU1498, or with the VEGF neutralizing antibody resulted in the reverse of the angiogenic effect on HUVECs. 

Phrase: "Furthermore,"

Phrase: "inhibition of VEGF function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1512280:Growth Factor Inhibition [Physiologic Function]
   804   C2249823:inhibition of growth [Organism Function]
   774   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with an Flk-1 inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C1504624:FLK-1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "SU1498,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1436360:SU1498 [Organic Chemical]

Phrase: "or with the VEGF neutralizing antibody"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0475463:Neutralising antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   762   C0443907:Endothelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "resulted in the reverse of the angiogenic effect"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0302600:Angiogenic [Organ or Tissue Function]
   744   C1280500:Effect [Qualitative Concept]
   744   C1555029:Reverse [Idea or Concept]
   744   C2348382:Effect [Qualitative Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "on HUVECs."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.13: Our results suggest that overexpression of Id-1 in prostate cancer cells may provide an autocrine signal to promote angiogenesis through the activation of VEGF. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in prostate cancer cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an autocrine signal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "angiogenesis through the activation of VEGF."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C0312818:Angiogenesis growth factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   784   C2249517:activation of angiogenesis [Organism Function]
   762   C0002976:Angiogenesis Factor [Biologically Active Substance]
   742   C0302600:Angiogenesis [Organ or Tissue Function]
   742   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.14: Since increased Id-1 has been reported in many types of advanced human cancers, our results indicate that downregulation of Id-1 may be a novel target to inhibit the growth of metastatic cancers through the suppression of angiogenesis. 

Phrase: "Since increased Id-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0309276:ID-1 [Pharmacologic Substance]
   812   C0205217:Increased [Quantitative Concept]
   812   C0442805:Increased [Functional Concept]
   812   C0600091:ID [Intellectual Product]
   812   C1711239:Since [Temporal Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported in many types of advanced human cancers,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   771   C0585733:Type of Report [Intellectual Product]
           Report types
   767   C0877373:Advanced Cancer [Neoplastic Process]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0086418:Human [Human]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0332307:Types [Qualitative Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0998265:Cancer [Eukaryote]
   744   C1306459:Cancer [Finding]
   744   C3496591:Reported [Clinical Attribute]
   711 E C1547052:*Type [Quantitative Concept]
   711 E C3273238:Report [Intellectual Product]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that downregulation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "may"

Phrase: "be"

Phrase: "a novel target to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the growth of metastatic cancers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "through the suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.15: Abbreviations: BMP, bone morphogenic protein; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "BMP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "bone morphogenic protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450131:Bone morphogenic protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.16: BrdU, bromodeoxyuridine; 

Phrase: "BrdU,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006233:Bromodeoxyuridine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "bromodeoxyuridine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006233:Bromodeoxyuridine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.17: DAPI, 4',6-diamidino-2-phenylindole; 

Phrase: "DAPI,"

Phrase: "4',"

Phrase: "6-diamidino-2-phenylindole"

Phrase: ";"
Processing 00000000.tx.18: EGM2, Endothelial Cell Medium-2; 

Phrase: "EGM2,"

Phrase: "Endothelial Cell Medium-2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0225336:Endothelial cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0009458:Medium [Intellectual Product]
   812   C0014257:Endothelial [Tissue]
   812   C0439536:Medium [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705217:Medium [Substance]
   812   C1948049:Cell [Spatial Concept]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.19: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.20: FCS, fetal calf serum; 

Phrase: "FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.21: HUVECs, human umbilical vein endothelial cells; 

Phrase: "HUVECs,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "human umbilical vein endothelial cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.22: Id-1, inhibitor of differentiation/DNA synthesis; 

Phrase: "Id-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "inhibitor of differentiation/DNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.23: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.24: VEGF, vascular endothelial growth factor  Introduction Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Id-1 (inhibitor of differentiation/DNA synthesis) protein belongs to the Id family of helixloophelix proteins. 

Phrase: "VEGF,"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "vascular endothelial growth factor  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C0440737:Blood material [Body Substance]
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "(inhibitor of differentiation/DNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1511940:Differentiation Inhibitor [Pharmacologic Substance]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "belongs to the Id family of helixloophelix proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0015576:Family [Family Group]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0600091:ID [Intellectual Product]
   744   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.25: It lacks the basic domain for DNA binding and functions mainly as a dominant inhibitor of the bHLH transcription factor through heterodimerization (1). 

Phrase: "It"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the basic domain for DNA binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1511662:DNA Binding Domain [Amino Acid Sequence]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "mainly as a dominant inhibitor of the bHLH transcription factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0960756:factor A [Organic Chemical]
   739   C0040649:Transcription [Genetic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1527180:Dominant [Functional Concept]
   739   C1999216:Inhibitor [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "through heterodimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512424:Heterodimerization [Molecular Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: Id-1 has been shown to play a critical role in the regulation of cell proliferation (2), differentiation (3) and senescence (46), and recent studies suggest that Id-1 may function as an oncogene. 

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in the regulation of cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "senescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231337:Senescence [Finding]
  1000   C1999167:Senescence [Population Group]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "may"

Phrase: "function as an oncogene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0029016:Oncogene [Gene or Genome]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.27: For example, Id-1 is shown to inhibit replicative senescence and promote life span of primary cells through the inactivation of p16/RB pathway (6). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "replicative senescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007581:Senescence, Replicative [Cell Function]
   861   C0231337:Senescence [Finding]
   861   C1999167:Senescence [Population Group]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "life span of primary cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870809:life span [Group Attribute]
   760   C0376558:Life [Idea or Concept]
   760   C1711300:Span [Conceptual Entity]
   760   C2700613:Span [Quantitative Concept]

Phrase: "through the inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of p16/RB pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.28: In addition, elevated Id-1 expression either at transcriptional or translational levels has been reported in over 20 types of human cancers including prostate, breast, cervical, colon and liver cancers (7). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "elevated Id-1 expression either at transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "translational levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported in over 20 types of human cancers"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   771   C0585733:Type of Report [Intellectual Product]
           Report types
   744   C0006826:Cancer [Neoplastic Process]
   744   C0086418:Human [Human]
   744   C0332307:Types [Qualitative Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0998265:Cancer [Eukaryote]
   744   C1306459:Cancer [Finding]
   744   C3496591:Reported [Clinical Attribute]
   711 E C1547052:*Type [Quantitative Concept]
   711 E C3273238:Report [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "breast,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "cervical,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027530:Cervical [Body Location or Region]
  1000   C0205064:Cervical [Spatial Concept]

Phrase: "colon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009368:Colon [Body Part, Organ, or Organ Component]
  1000   C1281569:Colon [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "liver cancers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0279000:Liver Cancer [Neoplastic Process]
  1000   C0345904:Liver Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.29: Furthermore, the ectopic expression of Id-1 promotes cancer cell proliferation and protection against apoptosis under sub-optimal culture conditions (2,8). 

Phrase: "Furthermore,"

Phrase: "the ectopic expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512167:Ectopic Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cancer cell proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0334227:Cancer Cell [Cell]

Phrase: "and"

Phrase: "protection against apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "under sub-optimal culture conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.30: In addition to its potential oncogenic actions, Id-1 has also been suggested to take part in the malignant progression of human cancer. 

Phrase: "In addition to its potential oncogenic actions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441472:actions [Functional Concept]
   793 E C3266814:Action [Activity]

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "part in the malignant progression of human cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1292711:Part of [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.31: For example, in breast cancer, Id-1 is found to be constitutively expressed in the highly aggressive but not the non-aggressive cancer cells (9). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "in breast cancer,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0006142:Breast Cancer [Neoplastic Process]
   901   C0678222:Breast Cancer [Neoplastic Process]
   851 E C0153661:thoracic cancer [Neoplastic Process]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "constitutively"

Phrase: "expressed in the highly aggressive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001807:aggressive [Mental or Behavioral Dysfunction]
   760   C0205250:Highly [Qualitative Concept]
   760   C0580822:Aggressive [Temporal Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the non-aggressive cancer cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0334227:cancer cells [Cell]
   861   C2945759:aggressive cancer [Neoplastic Process]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0007634:Cells [Cell]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.32: In endometrial carcinoma, Id-1 expression is also high in high grade and invasive tumours (10). 

Phrase: "In endometrial carcinoma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0476089:Endometrial Carcinoma [Neoplastic Process]
   861   C0007097:Carcinoma [Neoplastic Process]

Phrase: "Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "is"

Phrase: "also high in high grade"

Phrase: "and"

Phrase: "invasive tumours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027651:tumours [Neoplastic Process]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.33: Early stage cervical cancer patients with high Id-1 expression have poor prognosis compared with patients with relatively low Id-1 expression (11). 

Phrase: "Early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "cervical cancer patients with high Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1516213:Cancer Patient [Patient or Disabled Group]
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "poor prognosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0278252:Poor prognosis [Finding]
   861   C0033325:Prognosis [Health Care Activity]

Phrase: "compared with patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1707455:Compared [Activity]

Phrase: "with relatively low Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.34: In breast and cervical cancers, increased Id-1 is associated with more aggressive clinical behaviour as well as poor clinical outcome in patients (9,11,12). 

Phrase: "In breast"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]

Phrase: "and"

Phrase: "cervical cancers,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007847:cervical cancers [Neoplastic Process]
   966 E C0302592:Cervical Cancer [Neoplastic Process]
   966 E C3539064:Cervical Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0027530:Cervical [Body Location or Region]
   861   C0205064:Cervical [Spatial Concept]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "increased Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0309276:ID-1 [Pharmacologic Substance]
   827   C0205217:Increased [Quantitative Concept]
   827   C0442805:Increased [Functional Concept]
   827   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "associated with more aggressive clinical behaviour"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0001807:Aggressive behavior [Mental or Behavioral Dysfunction]
           aggressive
   753   C0004927:Behavior [Individual Behavior]
   753   C0205210:Clinical [Qualitative Concept]
   753   C0580822:Aggressive [Temporal Concept]
   753   C2707008:Behavior [Clinical Attribute]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as well as"

Phrase: "poor clinical outcome in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1547647:Patient Outcome [Idea or Concept]
   760   C1274040:Outcome [Functional Concept]

Phrase: "(9,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.35: In our previous studies, in human prostate cancer, Id-1 expression was found to be increased with increased Gleason score of the tumours (13) and ectopic expression of Id-1 in the androgen-sensitive prostate cancer cells led to decreased sensitivity to androgen-induced growth stimulation (14), which is a characteristic of prostate cancer progression. 

Phrase: "In our previous studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "in human prostate cancer,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0376358:Prostate Cancer [Neoplastic Process]
   901   C0600139:Prostate Cancer [Neoplastic Process]
   901   C2984325:Prostate cancer [Functional Concept]
   901   C3541264:Prostate Cancer [Intellectual Product]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0033572:Prostate [Body Part, Organ, or Organ Component]
   827   C0998265:Cancer [Eukaryote]
   827   C1278980:Prostate [Body Part, Organ, or Organ Component]
   827   C1306459:Cancer [Finding]

Phrase: "Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased with increased Gleason score of the tumours"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332326:gleason score [Classification]
   770   C3203027:Gleason score [Quantitative Concept]
   744   C0027651:tumours [Neoplastic Process]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0449820:Score [Quantitative Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "ectopic expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the androgen-sensitive prostate cancer cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0334227:cancer cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "led to decreased sensitivity"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   833   C0020580:Decreased Sensitivity [Finding]
   833   C1880261:DECREASED SENSITIVITY [Phenomenon or Process]
   833   C2348085:DECREASED SENSITIVITY [Phenomenon or Process]
   783   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0427965:Sensitivity [Finding]
   770   C0442797:decreased [Qualitative Concept]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C1708698:LED [Manufactured Object]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to androgen-induced growth stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "a characteristic of prostate cancer progression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.36: Furthermore, Id-1 is shown to stimulate mitogen-activated protein kinase (MAPK) and nuclear factor-B pathways (8,15), which are frequently activated in more advanced and aggressive cancers. 

Phrase: "Furthermore,"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "mitogen-activated protein kinase (MAPK)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "nuclear factor-B pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "(8,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "activated in more"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "advanced"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205179:Advanced [Qualitative Concept]
   966 E C0725066:Advance [Medical Device]

Phrase: "and"

Phrase: "aggressive cancers."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2945759:aggressive cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.37: These lines of evidence strongly suggest that Id-1 may be a key factor not only in promoting human tumourigenesis but it may also play an important part in tumour progression. 

Phrase: "These lines of evidence strongly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205132:lines [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "a key factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "not only in promoting human tumourigenesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007621:Tumorigenesis [Neoplastic Process]
   753   C0033414:Promoting [Activity]
   753   C0086418:Human [Human]
   753   C0205171:Only [Quantitative Concept]
   753   C0596263:Tumorigenesis [Neoplastic Process]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important part in tumour progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.38: One of the striking characteristics of the aggressive cancer cells is their ability to metastasize and develop an ectopic growth. 

Phrase: "One of the striking characteristics of the aggressive cancer cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "metastasize"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027627:Metastasize [Neoplastic Process]
  1000   C2939420:metastasize [Neoplastic Process]

Phrase: "and"

Phrase: "develop"

Phrase: "an ectopic growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.39: The most convincing evidence associating Id-1 with tumour metastasis are the results generated from knockout mice that Id-1 and Id-3 double knockout results in embryonic lethality in mice due to poor blood vessel formation in the brain. 

Phrase: "The most convincing evidence associating Id-1 with tumour metastasis"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   760   C0027627:tumor metastasis [Neoplastic Process]
           Metastasis
   760   C0309276:ID-1 [Pharmacologic Substance]
   760   C2939419:Tumor metastasis [Neoplastic Process]
   739   C0027651:Tumor [Neoplastic Process]
   739   C0332120:Evidence [Functional Concept]
   739   C0332281:associating [Qualitative Concept]
   739   C0600091:ID [Intellectual Product]
   739   C1578706:Tumor [Intellectual Product]
   739   C2939420:metastasis [Neoplastic Process]
       E   Metastatic Tumor
   739   C3273930:Tumor [Finding]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "generated from knockout mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0206745:Knock-out Mice [Mammal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0560617:knock out [Injury or Poisoning]
   770   C1522225:Knock-out [Experimental Model of Disease]
   770   C3146294:Generated [Activity]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "and"

Phrase: "Id-3 double knockout"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0560617:knock out [Injury or Poisoning]
   812   C1522225:Knock-out [Experimental Model of Disease]

Phrase: "results in embryonic lethality"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0013935:Embryonic [Embryonic Structure]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "due to poor blood vessel formation"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   861   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   861   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   861   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   805 E C1558950:VASCULAR [Finding]
   805 E C1801960:Vascular [Qualitative Concept]
   777 E C0005767:Blood [Tissue]
   777 E C0005768:blood [Body Substance]
   777 E C0229664:Blood [Body Substance]
   777 E C0392895:Bloods [Population Group]
   756 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.40: The Id-1/Id-3+/ mice also fail to support the growth of tumour xenografts owing to the poor vascularization that leads to necrosis of the tumour cells (16). 

Phrase: "The Id-1/Id-3+/ mice also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the growth of tumour xenografts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0598934:growth tumor [Neoplastic Process]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "owing to the poor vascularization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027686:Vascularisation [Pathologic Function]
   861   C0042382:Vascularisation [Functional Concept]

Phrase: "that"

Phrase: "leads to necrosis of the tumour cells"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   793   C1336835:Tumor Cell Necrosis [Finding]
   778   C0431085:Tumor cells [Cell]
   774   C0333516:Tumor necrosis [Neoplastic Process]
   762 E C0597032:Tumor Cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0027540:Necrosis [Organ or Tissue Function]
   748   C0027651:Tumor [Neoplastic Process]
   748   C0181586:leads [Medical Device]
   748   C1334928:Necrosis [Finding]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1578706:Tumor [Intellectual Product]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3273930:Tumor [Finding]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   738 E C1300818:Necrotic tumor [Neoplastic Process]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.41: In addition, loss of Id-1 is also associated with downregulation of several pro-angiogenic genes such as integrin6 and 4 in the tumour endothelial cells (17). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "loss of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "also"

Phrase: "associated with downregulation of several pro-angiogenic genes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   750   C0920533:Gene Down-Regulation [Genetic Function]
   744   C0013081:Down-Regulation [Cell Function,Molecular Function]
   744   C0017337:Genes [Gene or Genome]
   744   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0302600:Angiogenic [Organ or Tissue Function]
   744   C2987124:PRO [Intellectual Product]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as integrin6"

Phrase: "and"

Phrase: "4 in the tumour endothelial cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0225336:Endothelial Cells [Cell]
   783   C0431085:Tumor cells [Cell]
   767 E C0597032:Tumor Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0014257:Endothelial [Tissue]
   753   C0027651:Tumor [Neoplastic Process]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.42: Furthermore, downregulation of Id-1 in a breast cancer animal model leads to decreased metastatic ability of xenografts and reduced invasion ability in cultured cells (18). 

Phrase: "Furthermore,"

Phrase: "downregulation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "in a breast cancer animal model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1511291:Breast Cancer Model [Experimental Model of Disease]
   875   C1516211:Cancer Model [Experimental Model of Disease]
   861   C0599779:Animal Model [Animal]
   812   C0003062:Animal [Animal]
   812   C3161035:Model [Intellectual Product]

Phrase: "leads to decreased metastatic ability of xenografts"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   774   C0036525:Metastatic to [Functional Concept]
           Metastatic
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0085732:Ability [Organism Attribute]
   748   C0181586:leads [Medical Device]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0520484:xenografts [Therapeutic or Preventive Procedure]
   748   C0522537:Xenografts [Biomedical or Dental Material]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522484:metastatic [Quantitative Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "reduced invasion ability in cultured cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.43: These results raise a hypothesis that Id-1 may play a positive role in cancer metastasis through the promotion of angiogenesis. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "a hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a positive role in cancer metastasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "through the promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.44: However, the molecular basis for its role in cancer metastasis is not clear. 

Phrase: "However,"

Phrase: "the molecular basis for its role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "in cancer metastasis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0027627:Metastasis [Neoplastic Process]
   861   C2939420:metastasis [Neoplastic Process]
   789 E C0036525:Metastatic [Functional Concept]
   789 E C1522484:metastatic [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.45: Prostate cancer is one of the most commonly diagnosed cancers in American men representing one-third of all new cancer cases each year. 

Phrase: "Prostate cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]

Phrase: "is"

Phrase: "one of the most commonly diagnosed cancers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "in American men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "one-third of all new cancer cases"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0006826:Cancer [Neoplastic Process]
   748   C0205314:New [Temporal Concept]
   748   C0205437:Third [Quantitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0868928:Cases [Functional Concept]
   748   C0998265:Cancer [Eukaryote]
   748   C1306459:Cancer [Finding]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "each year."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439234:year [Temporal Concept]
  1000   C0439508:/year [Temporal Concept]
Processing 00000000.tx.46: This means one out of six American men being diagnosed with prostate cancer over the course of their lifetimes. 

Phrase: "This means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "one out of six American men"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "being"

Phrase: "diagnosed with prostate cancer"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0376358:Prostate Cancer [Neoplastic Process]
   833   C0600139:Prostate Cancer [Neoplastic Process]
   833   C2984325:Prostate cancer [Functional Concept]
   833   C3541264:Prostate Cancer [Intellectual Product]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0011900:Diagnosed [Finding]
   770   C0033572:Prostate [Body Part, Organ, or Organ Component]
   770   C0998265:Cancer [Eukaryote]
   770   C1278980:Prostate [Body Part, Organ, or Organ Component]
   770   C1306459:Cancer [Finding]

Phrase: "over the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of their lifetimes."
Processing 00000000.tx.47: As a result, over 30 000 men die each year from prostate cancer in the US (19). 

Phrase: "As a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "over 30 000 men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0025266:Men [Population Group]
   779 E C0024554:MAN [Finding]
   779 E C0086418:Man [Human]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "each year from prostate cancer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439234:year [Temporal Concept]
   760   C0439508:/year [Temporal Concept]

Phrase: "in the US (19"

Phrase: ")."
Processing 00000000.tx.48: Advanced androgen-sensitive prostate cancer is manageable with androgen depletion therapy. 

Phrase: "Advanced androgen-sensitive prostate cancer"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C0877373:Advanced Cancer [Neoplastic Process]
   840   C0376358:Prostate Cancer [Neoplastic Process]
   840   C0600139:Prostate Cancer [Neoplastic Process]
   840   C2984325:Prostate cancer [Functional Concept]
   840   C3541264:Prostate Cancer [Intellectual Product]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0033572:Prostate [Body Part, Organ, or Organ Component]
   804   C0998265:Cancer [Eukaryote]
   804   C1278980:Prostate [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]

Phrase: "is"

Phrase: "manageable with androgen depletion therapy."
Processing 00000000.tx.49: However, once prostate cancer recurs and becomes androgen-independent, especially at metastatic stage, the median survival of this group of patients is short due to the lack of effective treatment strategies (20). 

Phrase: "However,"

Phrase: "once"

Phrase: "prostate cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]

Phrase: "recurs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034897:recur [Phenomenon or Process]

Phrase: "and"

Phrase: "becomes"

Phrase: "androgen-independent, especially at metastatic stage,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0002844:Androgen [Hormone,Pharmacologic Substance]
   753   C0036525:Metastatic [Functional Concept]
   753   C0085862:Independent [Idea or Concept]
   753   C0205390:Stage [Temporal Concept]
   753   C1299583:Independent [Finding]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]
   753   C1522484:metastatic [Quantitative Concept]
   753   C3536949:Androgen [Pharmacologic Substance]

Phrase: "the median survival of this group of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]

Phrase: "is"

Phrase: "short due to the lack of effective treatment strategies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1282927:short [Qualitative Concept]
   742   C1806781:Short [Quantitative Concept]
   742   C2350002:Short [Quantitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.50: Therefore, androgen-independent metastatic prostate cancer remains the main cause of cancer related death in men. 

Phrase: "Therefore,"

Phrase: "androgen-independent metastatic prostate cancer"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   924   C1654637:androgen independent prostate cancer [Neoplastic Process]
   884   C0936223:Metastatic Prostate Cancer [Neoplastic Process]
   853   C0027627:metastatic cancer [Neoplastic Process]
   853   C0346957:metastatic cancer [Neoplastic Process]
   853   C2939419:Metastatic cancer [Neoplastic Process]
   853   C2939420:metastatic cancer [Neoplastic Process]
   840   C0376358:Prostate Cancer [Neoplastic Process]
   840   C0600139:Prostate Cancer [Neoplastic Process]
   840   C2984325:Prostate cancer [Functional Concept]
   840   C3541264:Prostate Cancer [Intellectual Product]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0033572:Prostate [Body Part, Organ, or Organ Component]
   804   C0998265:Cancer [Eukaryote]
   804   C1278980:Prostate [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]

Phrase: "remains"

Phrase: "the main cause of cancer related death"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0007465:Cause of Death [Finding]
           Death Cause
   804   C0804771:Cause of death [Clinical Attribute]
   774   C1516195:Cancer Cause [Biomedical Occupation or Discipline]
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "in men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.51: However, the molecular mechanisms leading to metastatic progression of prostate cancer are not known. 

Phrase: "However,"

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to metastatic progression of prostate cancer"
Meta Candidates (Total=29; Excluded=4; Pruned=0; Remaining=25)
   804   C0376358:Cancer of Prostate [Neoplastic Process]
           Prostate Cancer
   804   C0600139:Cancer of Prostate [Neoplastic Process]
           Prostate Cancer
   804   C0936223:Metastatic Prostate Cancer [Neoplastic Process]
   778   C2984325:Prostate cancer [Functional Concept]
   778   C3541264:Prostate Cancer [Intellectual Product]
   774   C0027627:metastatic cancer [Neoplastic Process]
   774   C0036525:Metastatic to [Functional Concept]
           Metastatic
   774   C0178874:cancer progression [Neoplastic Process]
   774   C0346957:metastatic cancer [Neoplastic Process]
   774   C1947901:Cancer Progression [Pathologic Function]
   774   C2939419:Metastatic cancer [Neoplastic Process]
   774   C2939420:metastatic cancer [Neoplastic Process]
   748   C0006826:Cancer [Neoplastic Process]
   748   C0033572:Prostate [Body Part, Organ, or Organ Component]
   748   C0242656:progression [Pathologic Function]
   748   C0332152:Leading [Temporal Concept]
   748   C0449258:Progression [Functional Concept]
   748   C0998265:Cancer [Eukaryote]
   748   C1278980:Prostate [Body Part, Organ, or Organ Component]
   748   C1306459:Cancer [Finding]
   748   C1522484:metastatic [Quantitative Concept]
   748   C1522538:Leading [Functional Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.52: In this study, we have demonstrated that overexpression of Id-1 may be a key factor in promoting metastatic growth of prostate cancer through the activation of vascular endothelial growth factor (VEGF). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "may"

Phrase: "be"

Phrase: "a key factor in promoting metastatic growth of prostate cancer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0960756:factor A [Organic Chemical]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]

Phrase: "through the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of vascular endothelial growth factor"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ")."
Processing 00000000.tx.53: Our results suggest that overexpression of Id-1 may provide an autocrine signal to facilitate ectopic growth of prostate cancer cells through the promotion of angiogenesis. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an autocrine signal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "facilitate"

Phrase: "ectopic growth of prostate cancer cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   809   C0007595:growth of cell [Cell Function]
           cells growth
   804   C1516170:Cancer Cell Growth [Neoplastic Process]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]

Phrase: "through the promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "of angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.54: Downregulation of Id-1 may provide a novel target to inhibit the growth of metastatic prostate cancer.  

Phrase: "Downregulation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a novel target to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the growth of metastatic prostate cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
Processing 00000000.tx.55: Materials and methods Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Cell culture conditions Human prostate adenocarcinoma cell lines (LNCaP and DU145) and human umbilical vein endothelial cells (HUVECs) were obtained from American Type Culture Collection (Rockville, MD). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture conditions Human prostate adenocarcinoma cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   894   C0682523:cell human lines [Cell]
   892   C0007600:Cell lines [Cell]
   812   C0007112:Prostate Adenocarcinoma [Neoplastic Process]
   793   C0001418:Adenocarcinoma [Neoplastic Process]
   793   C0033572:Prostate [Body Part, Organ, or Organ Component]
   793   C0205132:lines [Spatial Concept]
   793   C1278980:Prostate [Body Part, Organ, or Organ Component]
   760 E C1550648:Line [Substance]
   760 E C1552960:Line [Quantitative Concept]

Phrase: "(LNCaP"

Phrase: "and"

Phrase: "DU145"

Phrase: ")"

Phrase: "and"

Phrase: "human umbilical vein endothelial cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1301820:Obtained [Functional Concept]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "(Rockville,"

Phrase: "MD)."
Processing 00000000.tx.56: LNCaP and DU145 cells were maintained in RPMI1640 medium (Sigma, St Louis, MO) supplemented with 5% fetal calf serum (FCS) and penicillin/streptomycin. 

Phrase: "LNCaP"

Phrase: "and"

Phrase: "DU145 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in RPMI1640 medium"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C0024501:Maintain [Activity]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "supplemented with 5% fetal calf serum (FCS)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "penicillin/streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.57: HUVEC was grown in Endothelial Cell Medium-2 (EGM2; Clonetics, Camber Bio Science Walkersville Inc., Walkersville, MD) supplemented with 2% fetal bovine serum, hydrocortisone, ascorbic acid, hFGF, VEGF, hEGF, R3-IGF-1, GA-1000 and Heparin as recommended by the manufacturer. 

Phrase: "HUVEC"

Phrase: "was"

Phrase: "grown in Endothelial Cell Medium-2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0225336:Endothelial cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0009458:Medium [Intellectual Product]
   753   C0014257:Endothelial [Tissue]
   753   C0439536:Medium [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1705217:Medium [Substance]
   753   C1948049:Cell [Spatial Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "(EGM2"

Phrase: "; Clonetics,"

Phrase: "Camber Bio Science Walkersville Inc.,"

Phrase: "Walkersville,"

Phrase: "MD)"

Phrase: "supplemented with 2% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "hydrocortisone,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0020268:Hydrocortisone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699383:Cortenema [Pharmacologic Substance,Steroid]
   944 E C0699388:Cort-Dome [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699389:Cortef [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699393:Eldecort [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699396:Hydrocortone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0699402:Cortril [Hormone,Pharmacologic Substance,Steroid]

Phrase: "ascorbic acid,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   944 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   916 E C2349136:Vitamin C [Organic Chemical,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "hFGF,"

Phrase: "VEGF,"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "hEGF,"

Phrase: "R3-IGF-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "GA-1000"

Phrase: "and"

Phrase: "Heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "recommended by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034866:Recommended [Idea or Concept]
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
Processing 00000000.tx.58: HUVECs were used between passages 2 and 8. 

Phrase: "HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used between passages 2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737   C0439799:Passage [Spatial Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "8."
Processing 00000000.tx.59: All cells were maintained at 37C in 5% CO2. 

Phrase: "All cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "in 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.60: Generation of Id-1 and Si-Id-1 transfectants LNCaP-pBabe (vector control) and LNCaP-Id-1 transfectants (C14) were established as described previously (2). 

Phrase: "Generation of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "Si-Id-1 transfectants LNCaP-pBabe"

Phrase: "(vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "LNCaP-Id-1 transfectants"

Phrase: "(C14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302945:C-14 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.61: The vector control and the stable transfectants were maintained under the same conditions as the parental LNCaP cell line. 

Phrase: "The vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the stable transfectants"

Phrase: "were"

Phrase: "maintained under the same conditions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0445247:Same [Qualitative Concept]
   760   C1314677:Maintained [Functional Concept]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0024501:Maintain [Activity]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "as the parental LNCaP cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.62: Before use for the treatment of HUVECs, the culture medium was changed to RPMI containing 1% FCS for 24 h. 

Phrase: "Before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "use for the treatment of HUVECs,"
Meta Candidates (Total=29; Excluded=3; Pruned=0; Remaining=26)
   833   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   784   C1179017:Endothelial cell of vein [Cell]
   760   C0041637:Umbilical vein [Embryonic Structure]
   760   C0221313:Umbilical vein [Embryonic Structure]
   760   C0225336:Endothelial Cells [Cell]
   760   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   757   C0427861:Human cells [Laboratory or Test Result]
   757   C1524063:Use of [Functional Concept]
   751   C1179027:Endothelium of vein [Tissue]
           Vein Endothelium
   739   C0007634:Cells [Cell]
   739   C0014257:Endothelial [Tissue]
   739   C0039798:treatment [Functional Concept]
   739   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   739   C0042153:use [Functional Concept]
   739   C0042449:Vein [Body Part, Organ, or Organ Component]
   739   C0086418:Human [Human]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C0457083:Use [Functional Concept]
   739   C1278960:Vein [Body Part, Organ, or Organ Component]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C1947944:Use [Intellectual Product]
   739   C3282337:Cells [Cell]
   739   C3538994:TREATMENT [Research Activity]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to RPMI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% FCS for 24 h."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015965:Fetal [Embryonic Structure]
   748   C0229671:Serum [Body Substance]
   748   C0230445:Calf [Body Location or Region]
   748   C0521457:Fetal [Functional Concept]
   748   C1305418:Calf [Body Part, Organ, or Organ Component]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
Processing 00000000.tx.63: A stable Id-1 Si-RNA vector was generated using the GeneSuppressor system kit according to the manufacturer's instructions. 

Phrase: "A stable Id-1 Si-RNA vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0442335:Vector [Spatial Concept]
   799   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GeneSuppressor system kit according to the manufacturer's instructions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.64: Briefly, the primers containing the short hairpin RNA sequence targeting the Id-1 coding region were annealed and cloned into pSuppressor-Retro vector to generate the Si-RNA expression vector. 

Phrase: "Briefly,"

Phrase: "the primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the short hairpin RNA sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0162327:RNA Sequence [Nucleotide Sequence]
           Sequence
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   756   C2930586:Short Hairpin RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the Id-1 coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0079941:Coding Region [Gene or Genome]
   812   C0009219:Coding [Occupational Activity]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   779 E C0805701:Code [Intellectual Product]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "annealed"

Phrase: "and"

Phrase: "cloned into pSuppressor-Retro vector to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205095:Retro- [Spatial Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C0521438:RETRO [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "generate"

Phrase: "the Si-RNA expression vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.65: The sequences of the Si-Id-1 primers were si-Id-1-F, TCG AGG CTG TTA CTC ACG CCT CAA GGA AGC TTG CTT GAG GCG TGA GTA ACA GCC TTT TT; 

Phrase: "The sequences of the Si-Id-1 primers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C1547397:Sequence ID [Idea or Concept]
   744   C0162326:Sequences [Nucleotide Sequence]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "si-Id-1-F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]

Phrase: "TCG AGG CTG TTA CTC ACG CCT CAA GGA AGC TTG CTT GAG GCG TGA GTA ACA GCC TTT TT"

Phrase: ";"
Processing 00000000.tx.66: si-Id-1-R, CTA GAA AAA GGC TGT TAC TCA CGC CTC AAG CAA GCT TCC TTG AGG CGT GAG TAA CAG CC. 

Phrase: "si-Id-1-R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "CTA GAA AAA GGC TGT TAC TCA CGC CTC AAG CAA GCT TCC TTG AGG CGT GAG TAA CAG CC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C3538933:CC [Cell Component]
Processing 00000000.tx.67: The control vector was generated using the same procedures as the Si-RNA vector except that the short hairpin RNA sequence were replaced with non-sense sequences that are not homologous to the human genome. 

Phrase: "The control vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031249:control vector [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same procedures as the Si-RNA vector"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   744   C0025664:procedures [Intellectual Product]
   744   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   744   C2700391:procedures [Activity]
   711 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   711 E C3274430:PROCEDURE [Health Care Activity]
   711 E C3538935:Procedure [Idea or Concept]
   711 E C3539779:Procedure [Intellectual Product]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "the short hairpin RNA sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0162327:RNA Sequence [Nucleotide Sequence]
           Sequence
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   756   C2930586:Short Hairpin RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "replaced with non-sense"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0036658:sense [Organ or Tissue Function]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   770   C1518422:Non [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "not homologous to the human genome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homologous [Gene or Genome]
Processing 00000000.tx.68: The sequences of the control primers were si-Con-F, TCG AGC GTA TTG CCT AGC ATT ACG TGA TGC TTG ACG TAA TGC TAG GCA ATA CGC TTT TT; 

Phrase: "The sequences of the control primers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "si-Con-F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "TCG AGC GTA TTG CCT AGC ATT ACG TGA TGC TTG ACG TAA TGC TAG GCA ATA CGC TTT TT"

Phrase: ";"
Processing 00000000.tx.69: si-Con-R, CTA GAA AAA GCG TAT TGC CTA GCA TTS CGT CAA GCT TCA CGT AAT GCT AGG CAA TAC GC. 

Phrase: "si-Con-R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "CTA GAA AAA GCG TAT TGC CTA GCA TTS CGT CAA GCT TCA CGT AAT GCT AGG CAA TAC GC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C3537453:GC [Gene or Genome]
Processing 00000000.tx.70: The resulting vectors were then transfected into the packaging cell line 293 using Fugene 6 reagent. 

Phrase: "The resulting vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transfected into the packaging cell line 293"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0007600:Cell Line [Cell]
   748   C0007634:Cell [Cell]
   748   C0013194:Packaging [Medical Device]
   748   C0030176:Packaging [Human-caused Phenomenon or Process]
   748   C0205132:Line [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2828395:Packaging [Activity]
   714 E C2700580:Package [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fugene 6 reagent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   734   C0916399:FuGene 6 [Lipid]
Processing 00000000.tx.71: Retroviruses were collected 48 h later, mixed with polybrene (8 g/ml), and then incubated with DU145 cells. 

Phrase: "Retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035366:Retroviruses [Virus]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "48 h later,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "mixed with polybrene"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205430:Mixed [Functional Concept]
   790   C0282194:Polybrene [Organic Chemical,Pharmacologic Substance]
   790   C3160715:Mixed [Finding]
   756 E C1421951:MIX [Gene or Genome]
   756 E C1720722:Mix [Qualitative Concept]

Phrase: "(8 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with DU145 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.72: Positive Si-Id-1 clones were then selected in Neomycin (400 g/ml) and stable transfectants were isolated after 14 days drug selection. 

Phrase: "Positive Si-Id-1 clones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0009013:Clones [Cell]
   771 E C1522642:Clone [Tissue]
   721 E C1704387:Clonal [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "selected in Neomycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027603:Neomycin [Antibiotic,Carbohydrate]
   756   C1707391:Select [Activity]

Phrase: "(400 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "stable transfectants"

Phrase: "were"

Phrase: "isolated after 14 days drug selection."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0013227:Drug [Pharmacologic Substance]
   753   C0036576:selection [Genetic Function]
   753   C0205409:Isolated [Functional Concept]
   753   C0439228:days [Temporal Concept]
   753   C1254351:Drug [Pharmacologic Substance]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0370215:Isolate [Substance]
   719 E C0439505:/day [Temporal Concept]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.73: A vector control was generated from a pool of >20 individual clones transfected with the control vector. 

Phrase: "A vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "generated from a pool of >20 individual clones"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0009013:Clones [Cell]
   744   C0027361:Individual [Population Group]
   744   C0237401:Individual [Human]
   744   C0337051:Pool [Geographic Area]
   744   C1509144:pool [Clinical Attribute]
   744   C2349200:Pool [Functional Concept]
   744   C3146294:Generated [Activity]
   711 E C1522642:Clone [Tissue]

Phrase: "transfected with the control vector."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.74: Vascular endothelial growth factor protein quantification by enzyme-linked immunosorbent assay (ELISA) Same number of LNCaP, LNCaP-Id-1 transfectants (C14), LNCaP-pBabe, DU145-Si-Id-1 transfectants and the vector control cells (2 x 105 cells/well) were plated in six-well plates in RPMI containing 5% FCS. 

Phrase: "Vascular endothelial growth factor protein quantification by enzyme-linked immunosorbent assay (ELISA) Same number"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1709793:Quantification [Quantitative Concept]

Phrase: "of LNCaP,"

Phrase: "LNCaP-Id-1 transfectants"

Phrase: "(C14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302945:C-14 [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "LNCaP-pBabe,"

Phrase: "DU145-Si-Id-1 transfectants"

Phrase: "and"

Phrase: "the vector control cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   901   C0031249:vector control [Occupational Activity]
   827   C0007634:Cells [Cell]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243148:control [Qualitative Concept]
   827   C0442335:Vector [Spatial Concept]
   827   C1550141:Control [Substance]
   827   C1705099:Vector [Idea or Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(2 x 105 cells/well"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   840   C2347578:Cells/well [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C0205170:Well [Qualitative Concept]
   804   C0740116:+2 [Quantitative Concept]
   804   C2827735:2+ [Quantitative Concept]
   804   C2981700:2+ [Classification]
   804   C3146287:Well [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "plated in six-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C0205452:Six [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "plates in RPMI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005971:Plate [Medical Device]
   790   C1139930:plate [Medical Device]
   790   C3537155:Plate [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.75: The cells were allowed to grow for 48 h until they were 6070% confluent. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "until"

Phrase: "they"

Phrase: "were"

Phrase: "6070% confluent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205200:Confluent [Qualitative Concept]
Processing 00000000.tx.76: The growth medium was then removed and replaced with fresh RPMI containing 1% FCS. 

Phrase: "The growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "replaced with fresh RPMI"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0443224:Fresh [Qualitative Concept]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   770   C2827486:Fresh [Body Substance]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.77: The cells were incubated for a further 24 h until 80% confluency was attained. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for a further 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1517331:Further [Spatial Concept]
   719 E C0205108:far [Spatial Concept]

Phrase: "until 80% confluency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205200:Confluent [Qualitative Concept]

Phrase: "was"

Phrase: "attained."
Processing 00000000.tx.78: The medium was then harvested and filtered for the measurement of secretory VEGF. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "filtered for the measurement of secretory VEGF."
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   824   C2239222:Vascular Endothelial Growth Factor Measurement [Laboratory Procedure]
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   741   C0336600:Vascular filter [Medical Device]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C0242485:Measurement [Functional Concept]
   739   C1327616:Secretory [Cell Function]
   739   C1521761:Factor [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   724   C0014261:Endothelium, Vascular [Tissue]
   706   C0180860:Filter [Manufactured Object]
   706   C0581406:Filter [Medical Device]
   706   C1522664:Filter [Intellectual Product]
   706   C1704449:Filter [Conceptual Entity]
   706   C1704684:Filter [Medical Device]
   706   C1875155:FILTER [Medical Device]
Processing 00000000.tx.79: The remaining cells were collected and the viable cells were counted. 

Phrase: "The remaining cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "the viable cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1441322:Viable cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.80: VEGF present in the growth medium was measured using a Quantakine Human VEGF ELISA kit according to the manufacturer's instructions (R&D Systems, Minneapolis, MN). 

Phrase: "VEGF present in the growth medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Quantakine Human VEGF ELISA kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   788   C0812225:KIT [Medical Device]
   788   C1150635:KIT [Molecular Function]
   788   C1705212:Kit [Medical Device]
   788   C1705213:KIT [Medical Device]
   788   C3273202:Kit [Manufactured Object]

Phrase: "according to the manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "(R&D Systems,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "Minneapolis,"

Phrase: "MN"

Phrase: ")."
Processing 00000000.tx.81: The concentration of VEGF was measured as picograms per millilitre (pg/ml) in the growth medium and the results were then calculated as picograms of secreted VEGF per cell. 

Phrase: "The concentration of VEGF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   724   C0427728:Blood concentration [Laboratory or Test Result]
   724   C0699870:blood concentration [Quantitative Concept]
   724   C1313904:Blood concentration [Laboratory Procedure]

Phrase: "was"

Phrase: "measured as picograms per millilitre (pg/ml)"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   851   C0439297:Picogram per Milliliter [Quantitative Concept]
           picogram/milliliter
   760   C0439213:picograms [Quantitative Concept]
   760   C0439242:milliliter [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in the growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "calculated as picograms of secreted VEGF"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C0812231:secreted growth factor [Gene or Genome]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C0439213:picograms [Quantitative Concept]
   742   C0444686:Calculated [Functional Concept]
   742   C1327616:Secreted [Cell Function]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1521761:Factor [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "per cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.82: Each experiment was performed at least three times and the mean concentration of VEGF secretion was presented as the final result. 

Phrase: "Each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed at least three times"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the mean concentration of VEGF secretion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0086045:Concentration [Mental Process]
   742   C0444504:Mean [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C2347634:Mean [Quantitative Concept]
   742   C2348143:Mean [Quantitative Concept]
   712   C0427728:Blood concentration [Laboratory or Test Result]
   712   C0699870:blood concentration [Quantitative Concept]
   712   C1313904:Blood concentration [Laboratory Procedure]

Phrase: "was"

Phrase: "presented as the final result."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205088:Final [Temporal Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1546485:Final [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.83: Standard deviation (SD) of the means was used as error bars. 

Phrase: "Standard deviation (SD) of the means"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0871420:Standard deviation [Quantitative Concept]
   781   C1828170:Mean deviation [Clinical Attribute]
   760   C0012727:Deviation [Spatial Concept]
   760   C0205419:Deviation [Qualitative Concept]
   760   C1442989:Standard [Qualitative Concept]
   760   C1705236:Deviation [Finding]
   760   C2828392:Standard [Intellectual Product]

Phrase: "was"

Phrase: "used as error bars."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0743559:error [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1608199:Error [Functional Concept]
   770   C1707156:BARS [Gene or Genome]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.84: Luciferase assay LNCaP cells (1 x 105 cells/well) were plated into 12-well culture plates and allowed to grow for 24 h. 

Phrase: "Luciferase assay LNCaP cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(1 x 105 cells/well"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C2347578:Cells/well [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C0205170:Well [Qualitative Concept]
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]
   804   C3146287:Well [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "plated into 12-well culture plates"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0180454:culture plates [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1139930:plates [Medical Device]
           plate
   753   C2242979:Culture [Laboratory Procedure]
   753   C3146287:Well [Manufactured Object]
   719   C0005971:Plate [Medical Device]
   719   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.85: pGL-V109 (luciferase reporter containing the VEGF promoter, kindly donated by Dr K.Xie, The University of Texas, Houston, TX) and pRL-CMV-Luc were co-transfected with either the pcDNA-Id-1 (a gift from Dr Eiji Hara, Kyoto Prefectural University of Medicine, Kyoto, Japan) or pcDNA into the cells using Fugene 6 reagent (Roche Diagnostics, Indianapolis, IN). 

Phrase: "pGL-V109"

Phrase: "(luciferase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0335038:Reporter [Professional or Occupational Group]
   861   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   861   C1705915:Reporter [Conceptual Entity]
   861   C1709908:Reporter [Group]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the VEGF promoter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "kindly"

Phrase: "donated by Dr K.Xie,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0031831:DR [Professional or Occupational Group]
   760   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1708601:K' [Quantitative Concept]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: "The University of Texas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039711:Texas [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Houston,"

Phrase: "TX)"

Phrase: "and"

Phrase: "pRL-CMV-Luc"

Phrase: "were"

Phrase: "co-transfected with either"

Phrase: "the pcDNA-Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0309276:ID-1 [Pharmacologic Substance]
   827   C0600091:ID [Intellectual Product]

Phrase: "("

Phrase: "a gift from Dr Eiji Hara,"

Phrase: "Kyoto Prefectural University of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0041740:University [Manufactured Object,Organization]

Phrase: "Kyoto,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "pcDNA into the cells"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Fugene 6 reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   734   C0916399:FuGene 6 [Lipid]

Phrase: "(Roche Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.86: Cells were lysed 48 h after transfection and were assayed for luciferase activity using the Dual-luciferase reporter assay system (Promega, WI). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "48 h after transfection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "assayed for luciferase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Dual-luciferase reporter assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.87: For measuring VEGF promoter activity of the stable DU145-Si-Id-1 transfectants and the vector control, the cells were co-transfected with pGL-V109 and pRL-CMV-Luc vector. 

Phrase: "For measuring VEGF promoter activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C1760030:vascular endothelial growth factor activity [Molecular Function]
   852   C1149472:growth factor activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   710   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "of the stable DU145-Si-Id-1 transfectants"

Phrase: "and"

Phrase: "the vector control,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with pGL-V109"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030421:PGL [Neoplastic Process]
   760   C1150891:PGL [Molecular Function]
   760   C3273622:PGL [Gene or Genome]

Phrase: "and"

Phrase: "pRL-CMV-Luc vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.88: Firefly luciferase activity was measured at 48 h after transfection and the reading was then normalized with the Renilla luciferase activity, which served as the internal control for transfection efficiency. 

Phrase: "Firefly luciferase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1324397:firefly luciferase activity [Molecular Function]
   901   C1151115:luciferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured at 48 h"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0444706:Measured [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "the reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "normalized with the Renilla luciferase activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1151115:luciferase activity [Molecular Function]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1093003:Renilla [Eukaryote]
   753   C1561536:*Activity [Idea or Concept]
   753   C1882115:Normalized [Research Activity]

Phrase: "which"

Phrase: "served as the internal control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0597937:internal control [Mental Process]
   760   C0205102:Internal [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "for transfection efficiency."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]
Processing 00000000.tx.89: Each experiment was performed at least three times in duplicate wells and each data point represented the mean and SD. 

Phrase: "Each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed at least three times"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in duplicate wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "each data point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511726:Data Point [Idea or Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "SD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.90: The percentage increase in luciferase activity of the pcDNA-Id-1 transfected cells or the DU145-Si-Id-1 transfectants was calculated relative to that of the vector controls. 

Phrase: "The percentage increase in luciferase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "of the pcDNA-Id-1 transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "the DU145-Si-Id-1 transfectants"

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "relative to that of the vector controls."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.91: The mean percentage increase (or decrease) in luciferase activity was presented as the final result and the SD of the means was used as error bars. 

Phrase: "The mean percentage increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "or"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: "in luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "presented as the final result"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205088:Final [Temporal Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1546485:Final [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "the SD of the means"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0871420:Standard deviation [Quantitative Concept]
   767   C1828170:Mean deviation [Clinical Attribute]
   753   C0012727:Deviation [Spatial Concept]
   753   C0205419:Deviation [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C1705236:Deviation [Finding]
   753   C2828392:Standard [Intellectual Product]

Phrase: "was"

Phrase: "used as error bars."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0743559:error [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1608199:Error [Functional Concept]
   770   C1707156:BARS [Gene or Genome]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.92: Western blotting Cells, set in six-well plates for VEGF ELISA analysis, were lysed and proteins were extracted using the method described previously (2). 

Phrase: "Western blotting Cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   717 E C0949466:Western Blot [Laboratory Procedure]

Phrase: "set in six-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0036849:Set [Mental Process]
   812   C0205170:Well [Qualitative Concept]
   812   C0205452:Six [Quantitative Concept]
   812   C1442518:Set [Functional Concept]
   812   C1705195:Set [Conceptual Entity]
   812   C3146287:Well [Manufactured Object]

Phrase: "plates for VEGF ELISA analysis,"
Meta Candidates (Total=34; Excluded=0; Pruned=0; Remaining=34)
   797   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   797   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   775   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0014570:Growth Plate [Body Part, Organ, or Organ Component]
   754   C0018283:Growth Plate [Tissue]
   754   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   754   C0085801:Analysis, Factor [Quantitative Concept]
   754   C0441685:Plate assay [Laboratory Procedure]
   754   C2717977:Enzyme Assay [Laboratory Procedure]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0005507:Assay [Laboratory Procedure]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0005971:Plate [Medical Device]
   738   C0014257:Endothelial [Tissue]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   738   C0220844:growth [Physiologic Function]
   738   C0243073:assay [Qualitative Concept]
   738   C0936012:Analysis [Research Activity]
   738   C1139930:plate [Medical Device]
   738   C1510438:Assay [Laboratory Procedure]
   738   C1521761:Factor [Functional Concept]
   738   C1524024:analysis [Functional Concept]
   738   C1558950:VASCULAR [Finding]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1801960:Vascular [Qualitative Concept]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   738   C3537155:Plate [Manufactured Object]
   720   C0014261:Endothelium, Vascular [Tissue]
   704   C1517892:Link [Intellectual Product]
   704   C1704666:Link [Intellectual Product]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.93: By electrophoresis on 12.5% SDSpolyacrylamide gel an aliquot of 20 g of protein was separated and blotted onto polyvinylidene difluoride membranes (Amersham, Piscataway, NJ). 

Phrase: "By electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "on 12.5% SDSpolyacrylamide gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C1382104:Gel [Substance]

Phrase: "an aliquot of 20 g of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "blotted onto polyvinylidene difluoride membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Amersham,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.94: The membranes were blocked with 10% non-fat-milk in TBS-T for 1 h at room temperature. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked with 10% non-fat-milk"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0991850:fat milk [Lipid,Pharmacologic Substance]
   753   C0026131:Milk [Body Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C0349374:Milk [Food]
   753   C0424612:FAT [Organism Attribute]
   753   C0444318:Milk [Substance]
   753   C1518422:Non [Functional Concept]
   753   C2825079:Milk [Food]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "in TBS-T"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.95: After washing with TBS-T, the blots were incubated with primary antibody against Id-1 (1:1000, C20; 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with TBS-T,"

Phrase: "the blots"

Phrase: "were"

Phrase: "incubated with primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "against Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "C20"

Phrase: ";"
Processing 00000000.tx.96: Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h, and horseradish peroxidase-conjugated secondary antibody against rabbit IgG (1:3000; 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA) for 1 h,"

Phrase: "and"

Phrase: "horseradish peroxidase-conjugated secondary antibody against rabbit IgG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C2754943:IgG antibody [Cell Component]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "3000"

Phrase: ";"
Processing 00000000.tx.97: Amersham) for a further 1 h. 

Phrase: "Amersham"

Phrase: ")"

Phrase: "for a further 1 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.98: Immunoreactive signals were detected using the ECL plus western blotting system (Amersham). 

Phrase: "Immunoreactive signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL plus western blotting system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Amersham"

Phrase: ")."
Processing 00000000.tx.99: Capillary tube formation assay LNCaP, LNCaP-pBabe and LNCaP-Id-1 transfectants were plated into six-well plates (2 x 105 cells/well) in RPMI containing 5% FCS. 

Phrase: "Capillary tube formation assay LNCaP,"

Phrase: "LNCaP-pBabe"

Phrase: "and"

Phrase: "LNCaP-Id-1 transfectants"

Phrase: "were"

Phrase: "plated into six-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205170:Well [Qualitative Concept]
   770   C0205452:Six [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(2 x 105 cells/well"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   840   C2347578:Cells/well [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C0205170:Well [Qualitative Concept]
   804   C0740116:+2 [Quantitative Concept]
   804   C2827735:2+ [Quantitative Concept]
   804   C2981700:2+ [Classification]
   804   C3146287:Well [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in RPMI"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.100: After 48 h, the medium was removed and fresh medium (RPMI containing 1% FCS) was added. 

Phrase: "After 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "fresh medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(RPMI"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.101: The cells were allowed to grow for 24 h until they were 80% confluent. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "until"

Phrase: "they"

Phrase: "were"

Phrase: "80% confluent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205200:Confluent [Qualitative Concept]
Processing 00000000.tx.102: The growth medium was collected and filtered for the treatment of HUVECs. 

Phrase: "The growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "filtered for the treatment of HUVECs."
Meta Candidates (Total=32; Excluded=3; Pruned=0; Remaining=29)
   833   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   784   C1179017:Endothelial cell of vein [Cell]
   760   C0041637:Umbilical vein [Embryonic Structure]
   760   C0221313:Umbilical vein [Embryonic Structure]
   760   C0225336:Endothelial Cells [Cell]
   760   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   757   C0427861:Human cells [Laboratory or Test Result]
   751   C1179027:Endothelium of vein [Tissue]
           Vein Endothelium
   739   C0007634:Cells [Cell]
   739   C0014257:Endothelial [Tissue]
   739   C0039798:treatment [Functional Concept]
   739   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   739   C0042449:Vein [Body Part, Organ, or Organ Component]
   739   C0086418:Human [Human]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1278960:Vein [Body Part, Organ, or Organ Component]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3282337:Cells [Cell]
   739   C3538994:TREATMENT [Research Activity]
   706   C0180860:Filter [Manufactured Object]
   706   C0581406:Filter [Medical Device]
   706 E C1269647:Cell [Cell]
   706   C1522664:Filter [Intellectual Product]
   706   C1704449:Filter [Conceptual Entity]
   706 E C1704653:Cell [Medical Device]
   706   C1704684:Filter [Medical Device]
   706   C1875155:FILTER [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   705   C0007635:Cell Strain [Cell]
Processing 00000000.tx.103: In vitro angiogenesis assay on HUVECs was performed using the In vitro Angiogenesis Assay Kit (Chemicon International, Temecula, CA) according to the manufacturer's instructions. 

Phrase: "In vitro angiogenesis assay on HUVECs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C1515653:In Vitro Assay [Research Activity]
   739   C0005507:Assay [Laboratory Procedure]
   739   C0243073:assay [Qualitative Concept]
   739   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the In vitro Angiogenesis Assay Kit (Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1555271:Temecula [Population Group]

Phrase: "CA) according to the manufacturer's instructions."
Processing 00000000.tx.104: Briefly, HUVECs (1 x104 cells/well) were seeded onto polymerized three-dimensional collagen gel (ECMatrix, Chemicon International, Temecula, CA) in 96-well plates in the growth medium of LNCaP, LNCaP-pBabe and LNCaP-Id-1 transfectants. 

Phrase: "Briefly,"

Phrase: "HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(1 x104 cells/well"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C2347578:Cells/well [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C0205170:Well [Qualitative Concept]
   812   C1420745:X104 [Gene or Genome]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]
   812   C3146287:Well [Manufactured Object]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "seeded onto polymerized three-dimensional collagen gel"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0450363:3-Dimensional [Spatial Concept]
   748   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0205449:Three [Quantitative Concept]
   748   C0314672:Polymerized [Phenomenon or Process]
   748   C1167364:collagen [Cell Component]
   748   C1382104:Gel [Substance]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "(ECMatrix,"

Phrase: "Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA) in 96-well"

Phrase: "plates in the growth medium of LNCaP,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   774   C0014570:Growth Plate [Body Part, Organ, or Organ Component]
   774   C0018283:Growth Plate [Tissue]
   748   C0005971:Plate [Medical Device]
   748   C0009458:Medium [Intellectual Product]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0439536:Medium [Quantitative Concept]
   748   C1139930:plate [Medical Device]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1705217:Medium [Substance]
   748   C2911660:Growth [Activity]
   748   C3244283:medium [Intellectual Product]
   748   C3537155:Plate [Manufactured Object]

Phrase: "LNCaP-pBabe"

Phrase: "and"

Phrase: "LNCaP-Id-1 transfectants."
Processing 00000000.tx.105: RPMI medium (1% FCS) containing recombinant human VEGF (20 ng/ml; R&D Systems) and RPMI only were also used to culture HUVECs as positive and negative controls, respectively. 

Phrase: "RPMI medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(1% FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "recombinant human VEGF"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   947   C1171892:vascular endothelial growth factor, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   941   C1522575:Recombinant Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Vascular Endothelial Growth Factor
   904   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0014257:Endothelial [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C1801960:Vascular [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   791   C0014261:Endothelium, Vascular [Tissue]
   763 E C1706972:Blood Vessel Endothelium [Tissue]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "(20 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "RPMI only"

Phrase: "were"

Phrase: "also"

Phrase: "used to culture HUVECs"
Meta Candidates (Total=26; Excluded=6; Pruned=0; Remaining=20)
   869   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   770   C0041637:Umbilical vein [Embryonic Structure]
   770   C0221313:Umbilical vein [Embryonic Structure]
   770   C0225336:Endothelial Cells [Cell]
   770   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   767   C0007585:cells culture [Laboratory Procedure]
   767   C0427861:Human cells [Laboratory or Test Result]
   744   C0007634:Cells [Cell]
   744   C0010453:Culture [Idea or Concept]
   744   C0014257:Endothelial [Tissue]
   744   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   744   C0042449:Vein [Body Part, Organ, or Organ Component]
   744   C0086418:Human [Human]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C1273517:used [Finding]
   744   C1278960:Vein [Body Part, Organ, or Organ Component]
   744   C2242979:Culture [Laboratory Procedure]
   744   C3282337:Cells [Cell]
   735   C1179027:Vein Endothelium [Tissue]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1947944:Use [Intellectual Product]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "as positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.106: Tube formation in each treatment was inspected under an inverted light microscope after incubation for 8 h at 37C and the images were captured at a single level beneath the monolayer. 

Phrase: "Tube formation in each treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2752214:tube formation [Organ or Tissue Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "inspected under an inverted light microscope"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0491970:Light Microscope [Medical Device]
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C0181839:Microscope [Medical Device]
   753   C0443241:Inverted [Qualitative Concept]
   753   C1306462:Light [Functional Concept]
   753   C1706379:Microscope [Medical Device]
   753   C1881376:Light [Qualitative Concept]

Phrase: "after incubation"

Phrase: "for 8 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C"

Phrase: "and"

Phrase: "the images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured at a single level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "beneath the monolayer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872351:monolayer [Clinical Drug]
Processing 00000000.tx.107: Tube formation ability was quantified by counting the total number of cell cluster and branching under three 4x magnified fields per well. 

Phrase: "Tube formation ability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]
   734   C2752214:tube formation [Organ or Tissue Function]

Phrase: "was"

Phrase: "quantified by counting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "the total number of cell cluster"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "branching under three 4x magnified fields"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205384:Branching [Spatial Concept]

Phrase: "per well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.108: The results were expressed as the mean percentage of branching over total cell clusters. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "expressed as the mean percentage of branching"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205384:Branching [Spatial Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C0444504:Mean [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]

Phrase: "over total cell clusters."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   793   C1555715:Cluster [Idea or Concept]
   793   C1704332:Cluster [Quantitative Concept]
Processing 00000000.tx.109: For VEGF inhibition assay, Flk-1 kinase inhibitor (40 M, SU1498) (Calbiochem, San Diego, CA) was added to the growth medium of LNCaP and its transfectants and tube formation ability was determined as described above. 

Phrase: "For VEGF inhibition assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "Flk-1 kinase inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   861   C3537023:kinase inhibitor [Molecular Function]
   861   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(40 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "SU1498"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1436360:SU1498 [Organic Chemical]

Phrase: ")"

Phrase: "(Calbiochem,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "was"

Phrase: "added to the growth medium of LNCaP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Medium [Intellectual Product]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0439536:Medium [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1705217:Medium [Substance]
   748   C2911660:Growth [Activity]
   748   C3244283:medium [Intellectual Product]
   714 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "its transfectants"

Phrase: "and"

Phrase: "tube formation ability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]
   734   C2752214:tube formation [Organ or Tissue Function]

Phrase: "was"

Phrase: "determined as described above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.110: Northern blot Cells of LNCaP, DU145 and their transfectant clones were seeded on 10 cm tissue culture dishes for 24 h, and the medium was then replaced with RPMI supplemented with 1% FCS. 

Phrase: "Northern blot Cells of LNCaP,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "DU145"

Phrase: "and"

Phrase: "their transfectant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "seeded on 10 cm tissue culture dishes"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   797   C0492792:DISH, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "replaced with RPMI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0559956:Replaced [Functional Concept]
   790   C1299987:replaced [Functional Concept]
   756 E C1554078:Replace [Idea or Concept]

Phrase: "supplemented with 1% FCS."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.111: Forty-eight hours later, cells were lysed for total RNA extraction using Trizol reagent (Invitrogen, Carlsbad, CA) using the procedure provided by the manufacturer. 

Phrase: "Forty-eight hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed for total RNA extraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0024348:lysed [Pathologic Function]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Trizol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "provided by the manufacturer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0947322:Manufacturer [Intellectual Product]
   770   C1705426:Manufacturer [Population Group]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.112: mRNA was isolated from total RNA using the Oligotex mRNA kit (Qiagen, Valencia, CA) and 8 g of mRNA was then resolved by denaturing formaldehyde electrophoresis and transferred onto a nylon membrane by capillary blotting. 

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from total RNA"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205409:Isolated [Functional Concept]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Oligotex mRNA kit (Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "8 g of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resolved by denaturing formaldehyde electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred onto a nylon membrane"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "by capillary blotting."
Processing 00000000.tx.113: The blot was prehybridized in Expresshyb Hybridization solution (BD Clontech, Bedford, MA) at 68C for 2 h and was then hybridized overnight with the 32P-labelled cDNA probe complementary to the VEGF mRNA sequence (21). 

Phrase: "The blot"

Phrase: "was"

Phrase: "prehybridized in Expresshyb Hybridization solution"

Phrase: "(BD Clontech,"

Phrase: "Bedford,"

Phrase: "MA) at 68C"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "hybridized"

Phrase: "overnight with the 32P-labelled cDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0439583:Overnight [Temporal Concept]
   753   C1553631:32p [Medical Device]
   719   C0181496:Label [Manufactured Object]
   719   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "complementary to the VEGF mRNA sequence"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.114: The blot was then washed twice with SSC (0.15 M NaCl and 0.015 M sodium citrate) and then exposed to autoradiographic film for visualization. 

Phrase: "The blot"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with SSC (0.15 M NaCl"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0168944:M 15 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1720725:Twice [Intellectual Product]
   748   C1948050:Twice [Quantitative Concept]
   748   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.015 M sodium citrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   804   C0008857:Citrate [Organic Chemical]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to autoradiographic film"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0086296:Film [Manufactured Object]
   770   C1561571:film [Biomedical or Dental Material]
   770   C1561572:film [Substance]

Phrase: "for visualization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175631:Visualization [Mental Process]
  1000   C2827662:Visualization [Occupation or Discipline]
Processing 00000000.tx.115: Equal loading of the mRNA was confirmed by the visualization of 18S and 28S with ethidium bromide staining of the gel. 

Phrase: "Equal loading of the mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "confirmed by the visualization of 18S"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0175631:Visualization [Mental Process]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1552132:18s [Body Part, Organ, or Organ Component]
   753   C2827662:Visualization [Occupation or Discipline]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "28S with ethidium bromide staining of the gel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1552142:28s [Body Part, Organ, or Organ Component]
Processing 00000000.tx.116: VEGF RTPCR Total RNA was isolated using Trizol reagent according to the manufacturer's protocol (Invitrogen). 

Phrase: "VEGF RTPCR Total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   710   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Trizol reagent according to the manufacturer's protocol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.117: cDNA was synthesized using the SuperScript First Strand Synthesis System (Invitrogen) and was then amplified by PCR with VEGF specific primers (VEGE-f: 5'-TTCTGTATCAGTCTTTCCTGG-3' and VEGF-r: 5'-CGAAGTGGTGAAGTTCATGGA-3') (22). 

Phrase: "cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SuperScript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825228:Superscript [Intellectual Product]

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "Strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Synthesis System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "with VEGF specific primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(VEGE-f"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "5'-TTCTGTATCAGTCTTTCCTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "VEGF-r"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0034471:factor r [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205090:R- [Spatial Concept]
   804   C0684010:R. [Professional or Occupational Group]
   804   C2603358:R' [Clinical Attribute]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "5'-CGAAGTGGTGAAGTTCATGGA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.118: PCR cycling protocol was as follows: 30 cycles of 10 min at 95C, 30 s at 95C, 30 s at 55C, 1 min at 72C and 10 min at 72C. 

Phrase: "PCR cycling protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "30 cycles of 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C2348028:Cycle/min [Quantitative Concept]
   726   C1511572:Cycle [Temporal Concept]

Phrase: "at 95C,"

Phrase: "30 s at 95C,"

Phrase: "30 s at 55C,"

Phrase: "1 min at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "10 min at 72C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
Processing 00000000.tx.119: Glyceraldehyde 3-phosphate dehydrogenase was amplified as an internal control. 

Phrase: "Glyceraldehyde 3-phosphate dehydrogenase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
  1000   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   923   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "amplified as an internal control."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0597937:internal control [Mental Process]
   760   C0205102:Internal [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.120: The PCR products were electrophoresed on a 2% agarose gel and analysed using a gel documentation system. 

Phrase: "The PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on a 2% agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C1382104:Gel [Substance]
   719   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "analysed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a gel documentation system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.121: Bromodeoxyuridine (BrdU) staining Detailed experimental procedures were described in our previous studies (23). 

Phrase: "Bromodeoxyuridine (BrdU) staining Detailed experimental procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   804   C0025664:procedures [Intellectual Product]
   804   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C2700391:procedures [Activity]
   771 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   771 E C3274430:PROCEDURE [Health Care Activity]
   771 E C3538935:Procedure [Idea or Concept]
   771 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "described in our previous studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205156:Previous [Temporal Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   760   C1552738:described [Idea or Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.122: Briefly, HUVECs (6000 cells/well) were grown on Chamber slides in EGM2 for 24 h. 

Phrase: "Briefly,"

Phrase: "HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(6000 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "grown on Chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "slides in EGM2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444330:Slide [Research Device]
   790   C1705201:Slide [Manufactured Object]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.123: The culture medium was removed and replaced with the growth medium of LNCaP and its transfectants, 20 ng/ml rhVEGF in RPMI with 1% FCS, EGM2 and RPMI containing 1% FCS, respectively, for incubation of 24 h. 

Phrase: "The culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "replaced with the growth medium of LNCaP"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Medium [Intellectual Product]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0439536:Medium [Quantitative Concept]
   748   C0559956:Replaced [Functional Concept]
   748   C1299987:replaced [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1705217:Medium [Substance]
   748   C2911660:Growth [Activity]
   748   C3244283:medium [Intellectual Product]
   714 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "its transfectants,"

Phrase: "20 ng/ml rhVEGF in RPMI"

Phrase: "with 1% FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "EGM2"

Phrase: "and"

Phrase: "RPMI"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "respectively,"

Phrase: "for incubation"

Phrase: "of 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.124: The treatment medium was then removed and EGM2 was added for incubation for a further 24 h. 

Phrase: "The treatment medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "EGM2"

Phrase: "was"

Phrase: "added for incubation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "for a further 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.125: The cells were then stained with BrdUrd (10 M) for 2 h and again stained with fluorescein isothiocyanate antibody against BrdU as described previously (23). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with BrdUrd"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(10"

Phrase: "M) for 2 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "again"

Phrase: "stained with fluorescein isothiocyanate antibody"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   781   C0060520:Fluorescein stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Fluorescein
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0124209:Isothiocyanate [Organic Chemical]
   760   C0206359:isothiocyanate [Organic Chemical]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "against BrdU"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006233:Bromodeoxyuridine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.126: At least 1000 cells were counted in each experiment and results represented as the percentage of BrdU positive cells. 

Phrase: "At least 1000 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted in each experiment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represented as the percentage of BrdU positive cells."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C0439178:% positive cells [Quantitative Concept]
           % Positive
   744   C0006233:Bromodeoxyuridine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0007634:Cells [Cell]
   744   C0439165:Percentage [Quantitative Concept]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C1549488:Percentage [Idea or Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C2825490:Positive [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1882932:Represent [Activity]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.127: Immunohistochemistry The establishment of CWR22 and CWR22R human prostate xenografts has been described previously (24,25). 

Phrase: "Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "The establishment of CWR22"

Phrase: "and"

Phrase: "CWR22R human prostate xenografts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520484:xenografts [Therapeutic or Preventive Procedure]
   812   C0522537:Xenografts [Biomedical or Dental Material]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.128: Both the xenografts have been successfully propagated with androgen supply in male nude mice (for CWR22) or castrated male nude mice (for CWR22R) in our laboratory. 

Phrase: "Both"

Phrase: "the xenografts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520484:xenografts [Therapeutic or Preventive Procedure]
  1000   C0522537:Xenografts [Biomedical or Dental Material]

Phrase: "have"

Phrase: "been"

Phrase: "successfully"

Phrase: "propagated with androgen supply"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002844:Androgen [Hormone,Pharmacologic Substance]
   770   C0243163:supply [Idea or Concept]
   770   C0699914:supply [Quantitative Concept]
   770   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   770   C1561604:supply [Functional Concept]
   770   C1875802:SUPPLY [Medical Device]
   770   C1999230:Supply [Activity]
   770   C3536949:Androgen [Pharmacologic Substance]

Phrase: "in male nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025932:Mice, Nude [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C1425014:NUDE [Gene or Genome]

Phrase: "("

Phrase: "for CWR22"

Phrase: ")"

Phrase: "or"

Phrase: "castrated male nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025932:Mice, Nude [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C1425014:NUDE [Gene or Genome]

Phrase: "("

Phrase: "for CWR22R"

Phrase: ")"

Phrase: "in our laboratory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.129: Immunohistochemical staining was performed on 4 m sections from the formalin-fixed, paraffin-embedded CWR22 and CWR22R tumour specimens using the standard avidinbiotin complex procedure as described in our previous studies (13,14). 

Phrase: "Immunohistochemical staining"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "performed on 4 m sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from the formalin-fixed, paraffin-embedded CWR22"

Phrase: "and"

Phrase: "CWR22R tumour specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the standard avidinbiotin complex procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1292781:Complex procedure [Health Care Activity]
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "as"

Phrase: "described in our previous studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205156:Previous [Temporal Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   760   C1552738:described [Idea or Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.130: The primary and secondary antibodies used against Id-1 and VEGF have been described in Western blotting section. 

Phrase: "The primary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205225:Primary [Qualitative Concept]
  1000   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used against Id-1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0309276:ID-1 [Pharmacologic Substance]
   770   C0600091:ID [Intellectual Product]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "have"

Phrase: "been"

Phrase: "described in Western blotting section."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C0205155:Section [Spatial Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1522472:Section [Substance]
   760   C1552738:described [Idea or Concept]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.131: Photos were taken under 400x magnifications. 

Phrase: "Photos"

Phrase: "were"

Phrase: "taken under 400x magnifications."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.132: Detection of apoptotic cells by 4',6-diamidino-2-phenylindole (DAPI) staining Apoptotic cells were detected by DAPI nuclear staining according to the procedure described previously (8). 

Phrase: "Detection of apoptotic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   991   C1819992:detection of apoptotic cell [Cell Function]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by 4',"

Phrase: "6-diamidino-2-phenylindole (DAPI) staining Apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detected by DAPI nuclear staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0442726:Detected [Finding]
   748   C0487602:Staining [Laboratory Procedure]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1704680:Staining [Finding]

Phrase: "according to the procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.133: Briefly, HUVECs were plated onto a 12 mm cover glass and the rhVEGF was added alone or together with SU1498. 

Phrase: "Briefly,"

Phrase: "HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated onto a 12 mm cover glass"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0017596:Glass [Manufactured Object]
   748   C0180153:cover [Medical Device]
   748   C1707529:Cover [Medical Device]
   748   C1947936:Glass [Medical Device]
   748   C1999244:Cover [Functional Concept]
   714   C0005971:Plate [Medical Device]
   714   C1139930:plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "the rhVEGF"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or together with SU1498."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1436360:SU1498 [Organic Chemical]
   770   C1883357:Together [Qualitative Concept]
Processing 00000000.tx.134: They were fixed in ice-cold acetone and methanol (1:1), washed with phosphate-buffered saline, and then stained with DAPI for 5 min. 

Phrase: "They"

Phrase: "were"

Phrase: "fixed in ice-cold acetone"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0231441:Fixed [Finding]
   760   C0234192:Cold [Physiologic Function]
   760   C0443218:Fixed [Qualitative Concept]
   760   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "methanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "washed with phosphate-buffered saline,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "stained with DAPI"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.135: The stained cells were examined under a fluorescent microscope.  

Phrase: "The stained cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "examined under a fluorescent microscope."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0181839:Microscope [Medical Device]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332128:Examined [Finding]
   760   C1706379:Microscope [Medical Device]
Processing 00000000.tx.136: Results Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Ectopic expression of Id-1 leads to upregulation of VEGF in prostate cancer cells Previously, it was reported that VEGF protein expression was relatively low in LNCaP cells compared with the androgen-independent cell lines such as DU145 (26). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ectopic expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to upregulation of VEGF"
Meta Candidates (Total=26; Excluded=1; Pruned=0; Remaining=25)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1160196:up-regulation of growth [Organism Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0041904:Up-Regulation [Cell Function,Molecular Function]
   744   C0162493:Up-Regulation [Genetic Function]
   744   C0181586:leads [Medical Device]
   744   C0220844:growth [Physiologic Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1521761:Factor [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   735   C0014261:Endothelium, Vascular [Tissue]
   717   C0853362:blood lead [Laboratory Procedure]
   707 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "in prostate cancer cells Previously,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0334227:cancer cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that VEGF protein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "relatively low in LNCaP cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]

Phrase: "compared with the androgen-independent cell lines"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0007600:Cell lines [Cell]
   748   C0002844:Androgen [Hormone,Pharmacologic Substance]
   748   C0007634:Cell [Cell]
   748   C0085862:Independent [Idea or Concept]
   748   C0205132:lines [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1299583:Independent [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1707455:Compared [Activity]
   748   C1948049:Cell [Spatial Concept]
   748   C3536949:Androgen [Pharmacologic Substance]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "such as DU145"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.137: In addition, previously, we have found that Id-1 protein was also undetectable in LNCaP cells under serum-free culture conditions (2). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "previously,"

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Id-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "was"

Phrase: "also undetectable in LNCaP cells"

Phrase: "under serum-free culture conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.138: In this study, we investigated if ectopic Id-1 expression in LNCaP cells could lead to the upregulation of VEGF secretion. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "if"

Phrase: "ectopic Id-1 expression in LNCaP cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1512167:Ectopic Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "lead to the upregulation of VEGF secretion."
Meta Candidates (Total=27; Excluded=0; Pruned=0; Remaining=27)
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C1160196:up-regulation of growth [Organism Function]
   777   C1523072:up-regulation of secretion [Cell Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0041904:Up-Regulation [Cell Function,Molecular Function]
   739   C0162493:Up-Regulation [Genetic Function]
   739   C0220844:growth [Physiologic Function]
   739   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   739   C1521761:Factor [Functional Concept]
   739   C1522538:Lead [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2348269:Lead [Element, Ion, or Isotope]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3275067:LEAD [Therapeutic or Preventive Procedure]
   724   C0014261:Endothelium, Vascular [Tissue]
   707   C0853362:blood lead [Laboratory Procedure]
Processing 00000000.tx.139: Using four transfectant clones (Id-1-C1 to C4) generated from a previous study (2) (Figure 1A), we quantified the VEGF protein in the culture media of the parental cells, the vector control (pBabe) and the Id-1 expressing clones (C1 to C4) using ELISA method. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "four transfectant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(Id-1-C1 to C4)"

Phrase: "generated from a previous study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205156:Previous [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1552607:previous [Temporal Concept]
   760   C2603343:Study [Research Activity]
   760   C3146294:Generated [Activity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "(Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "quantified"

Phrase: "the VEGF protein in the culture media"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of the parental cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(pBabe"

Phrase: ")"

Phrase: "and"

Phrase: "the Id-1 expressing clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(C1 to C4)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ELISA method."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C0450074:Enzyme method [Intellectual Product]
   853   C1532280:Immunosorbent method [Laboratory Procedure]
   804   C0025663:Method [Intellectual Product]
   804   C0449851:Method [Functional Concept]
   804   C0871511:METHOD [Intellectual Product]
   771   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   708   C2717977:Enzyme Assay [Laboratory Procedure]
Processing 00000000.tx.140: As shown in Figure 1B, compared with LNCaP cells, there was 4080% increase in VEGF protein concentrations in the Id-1 transfectants with actual concentrations ranging from 19.5 to 34.5 ng/ml, while the VEGF level was similar to the parental line in pBabe cells, indicating that ectopic Id-1 expression led to increased secretion of VEGF in LNCaP cells. 

Phrase: "As"

Phrase: "shown in Figure 1B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450345:1B [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "compared with LNCaP cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "there"

Phrase: "was"

Phrase: "4080% increase in VEGF protein concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C2267118:Vascular Growth Increase [Physiologic Function]
   742   C0442805:Increase [Functional Concept]

Phrase: "in the Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "with actual concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "ranging from 19.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 34.5 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439275:ng/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "while"

Phrase: "the VEGF level"
Meta Candidates (Total=26; Excluded=7; Pruned=0; Remaining=19)
   937   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0014257:Endothelial [Tissue]
   804   C0014261:Endothelium, Vascular [Tissue]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1521761:Factor [Functional Concept]
   804   C1547707:Level [Geographic Area]
   804   C1558950:VASCULAR [Finding]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C1801960:Vascular [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C2946261:Level [Pharmacologic Substance]
   776 E C1706972:Blood Vessel Endothelium [Tissue]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "was"

Phrase: "similar to the parental line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in pBabe cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that ectopic Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1512167:Ectopic Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "led to increased secretion of VEGF"
Meta Candidates (Total=28; Excluded=6; Pruned=0; Remaining=22)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   762   C0333957:Increased growth [Pathologic Function]
   745   C0861064:increased lead [Finding]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0205217:Increased [Quantitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0442805:Increased [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1708698:LED [Manufactured Object]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "in LNCaP cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.141: To investigate whether the increased VEGF secretion in the Id-1 transfectants was due to gene activation at the transcriptional level, we then co-transfected the Id-1 expression vector (pcDNA-Id-1) together with a luciferase reporter containing the VEGF promoter in LNCaP cells and generated transient transfectants. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the increased VEGF secretion in the Id-1 transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0036536:secretion [Biologic Function]
   736   C0036537:Secretion [Body Substance]

Phrase: "was due to gene activation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0017255:Gene Activation [Genetic Function]
   806   C0678226:Due to [Functional Concept]
           due
   797   C1421478:WAS gene [Gene or Genome]
           WAS
   760   C0017337:Gene [Gene or Genome]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1879547:Activation [Activity]
   760   C3146286:Due [Idea or Concept]

Phrase: "at the transcriptional level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "we then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "co-transfected"

Phrase: "the Id-1 expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "(pcDNA-Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0309276:ID-1 [Pharmacologic Substance]
   827   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: "together with a luciferase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0335038:Reporter [Professional or Occupational Group]
   861   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   861   C1705915:Reporter [Conceptual Entity]
   861   C1709908:Reporter [Group]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the VEGF promoter in LNCaP cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "generated transient transfectants."
Processing 00000000.tx.142: We found that the VEGF promoter activity was increased by >2-fold in the Id-1 transfectants when compared with the vector control (Figure 1C). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the VEGF promoter activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   941   C1760030:vascular endothelial growth factor activity [Molecular Function]
   867   C1149472:growth factor activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "increased by"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0205217:Increased [Quantitative Concept]
   833   C0442805:Increased [Functional Concept]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]
   740 E C1706701:Acquire [Activity]
   740 E C3245488:acquired [Intellectual Product]

Phrase: ">2-fold in the Id-1 transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "when"

Phrase: "compared with the vector control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0031249:vector control [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243148:control [Qualitative Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1550141:Control [Substance]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Figure 1C"

Phrase: ")."
Processing 00000000.tx.143: To further confirm that the VEGF gene expression was upregulated by Id-1, we performed northern blotting as well as semi-quantitative RTPCR to quantify the mRNA level of the VEGF. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the VEGF gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0812325:Growth Factor Gene [Gene or Genome]
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "upregulated by Id-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0309276:ID-1 [Pharmacologic Substance]
   770   C0600091:ID [Intellectual Product]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "northern blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005861:Northern Blotting [Molecular Biology Research Technique]
   983 E C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "as well as"

Phrase: "semi-quantitative RTPCR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   812   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the mRNA level of the VEGF."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.144: As shown in Figure 1D and E, VEGF transcript was upregulated in the Id-1 transfectant, indicating that ectopic Id-1 expression led to increased transcriptional activation of the VEGF gene. 

Phrase: "As"

Phrase: "shown in Figure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "E,"

Phrase: "VEGF transcript"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "upregulated in the Id-1 transfectant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0600091:ID [Intellectual Product]

Phrase: "indicating"

Phrase: "that ectopic Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1512167:Ectopic Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "led to increased transcriptional activation of the VEGF gene."
Meta Candidates (Total=35; Excluded=5; Pruned=0; Remaining=30)
   790   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0812325:Growth Factor Gene [Gene or Genome]
   767   C2249824:activation of growth [Organism Function]
   753   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0162493:Transcriptional Activation [Genetic Function]
   751   C0017255:Gene Activation [Genetic Function]
   751   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   751   C0333957:Increased growth [Pathologic Function]
   743   C0812327:Transcription Factor Gene [Gene or Genome]
   736   C0005847:vascular [Body Part, Organ, or Organ Component]
   736   C0014257:Endothelial [Tissue]
   736   C0017337:Gene [Gene or Genome]
   736   C0018270:'growth' NOS [Organism Function]
   736   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   736   C0205217:Increased [Quantitative Concept]
   736   C0220844:growth [Physiologic Function]
   736   C0442805:Increased [Functional Concept]
   736   C1521761:Factor [Functional Concept]
   736   C1558950:VASCULAR [Finding]
   736   C1621966:Growth [Organ or Tissue Function]
   736   C1708698:LED [Manufactured Object]
   736   C1801960:Vascular [Qualitative Concept]
   736   C1879547:Activation [Activity]
   736   C2827422:Factor [Conceptual Entity]
   736   C2911660:Growth [Activity]
   734   C0861064:increased lead [Finding]
   717   C0014261:Endothelium, Vascular [Tissue]
   715   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   703 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   703 E C1522538:Lead [Functional Concept]
   703 E C2348269:Lead [Element, Ion, or Isotope]
   703 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.145: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.146: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.147: Id-1-induced VEGF activation in prostate cancer cells. 

Phrase: "Id-1-induced VEGF activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1879547:Activation [Activity]

Phrase: "in prostate cancer cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]
Processing 00000000.tx.148: (A) Id-1 expression in LNCaP, Id-1 transfectants and vector control demonstrated by western blotting. 

Phrase: "(A) Id-1 expression in LNCaP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "demonstrated by western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.149: (B) Secretory VEGF in the culture media of LNCaP, Id-1 transfectants (C1C4) and the vector control (pBabe) cells. 

Phrase: "(B) Secretory VEGF in the culture media"
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   824   C0388176:Vascular Endothelial Growth Factor B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   824   C1421446:VASCULAR ENDOTHELIAL GROWTH FACTOR B [Gene or Genome]
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   757   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   757   C0046774:B-factor [Nucleic Acid, Nucleoside, or Nucleotide]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   757   C0162867:Vascular Media [Tissue]
   757   C1824728:FACTOR B [Gene or Genome]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0220844:growth [Physiologic Function]
   739   C1521761:Factor [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   724   C0014261:Endothelium, Vascular [Tissue]
   707   C0200949:Blood culture [Laboratory Procedure]
   707   C0554854:Culture - blood [Finding]

Phrase: "of LNCaP,"

Phrase: "Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "(C1C4"

Phrase: ")"

Phrase: "and"

Phrase: "the vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(pBabe"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.150: VEGF protein concentration was measured by ELISA method and results presented as pictogram per cell. 

Phrase: "VEGF protein concentration"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   845   C0427728:Blood concentration [Laboratory or Test Result]
   845   C0699870:blood concentration [Quantitative Concept]
   845   C1313904:Blood concentration [Laboratory Procedure]
   827   C0427716:Protein concentration [Laboratory Procedure]
   827   C1304757:Protein concentration [Laboratory or Test Result]
   799   C0086045:Concentration [Mental Process]
   799   C1446561:Concentration [Quantitative Concept]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   727 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured by ELISA method"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   853   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   774   C0450074:Enzyme method [Intellectual Product]
   774   C1532280:Immunosorbent method [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   748   C0025663:Method [Intellectual Product]
   748   C0243073:assay [Qualitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1510438:Assay [Laboratory Procedure]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented as pictogram"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "per cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.151: (C) VEGF promoter activity in LNCaP cells transfected with pcDNA-Id-1 and pcDNA vectors. 

Phrase: "(C) VEGF promoter activity in LNCaP cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   824   C1760030:vascular endothelial growth factor activity [Molecular Function]
   777   C1149472:growth factor activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "transfected with pcDNA-Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0309276:ID-1 [Pharmacologic Substance]
   760   C0600091:ID [Intellectual Product]

Phrase: "and"

Phrase: "pcDNA vectors."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]
Processing 00000000.tx.152: pGL-V109 and pRL-CMV-Luc were co-transfected with either pcDNA-Id-1 or pcDNA into LNCaP cells. 

Phrase: "pGL-V109"

Phrase: "and"

Phrase: "pRL-CMV-Luc"

Phrase: "were"

Phrase: "co-transfected with either pcDNA-Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0600091:ID [Intellectual Product]

Phrase: "or"

Phrase: "pcDNA into LNCaP cells."
Processing 00000000.tx.153: Luciferase activity was measured 48 h after the transfection. 

Phrase: "Luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "48 h after the transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.154: Results represent three independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.155: (D and E) mRNA level of VEGF in vector control and Id-1 transfectant demonstrated by semi-quantitative RTPCR and northern blotting. 

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E) mRNA level of VEGF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Id-1 transfectant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "demonstrated by semi-quantitative RTPCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0522525:Semi-quantitative [Quantitative Concept]
   806   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "northern blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005861:Northern Blotting [Molecular Biology Research Technique]
   983 E C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.156: (D) Complementary DNA was synthesized by reverse transcription and then amplified with VEGF specific primer with conditions described in Materials and methods. 

Phrase: "("

Phrase: "D)"

Phrase: "Complementary DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "synthesized by reverse transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0035380:Reverse Transcription [Genetic Function]
   770   C0040649:Transcription [Genetic Function]
   770   C1555029:Reverse [Idea or Concept]
   770   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "amplified with VEGF specific primer"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205369:Specific [Qualitative Concept]
   744   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   735   C0014261:Endothelium, Vascular [Tissue]
   707 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "with conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.157: GADPH was amplified as internal control. 

Phrase: "GADPH"

Phrase: "was"

Phrase: "amplified as internal control."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0597937:internal control [Mental Process]
   770   C0205102:Internal [Spatial Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1553872:Internal [Intellectual Product]
   770   C1619620:Internal [Intellectual Product]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.158: (E) mRNA was resolved in agarose gel, transferred onto polyvinylidene difluoride membrane and then hybridized with VEGF specific probe. 

Phrase: "(E) mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "resolved in agarose gel,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1706746:Agarose Gel [Research Device]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0036681:Agarose [Carbohydrate]
   770   C1382104:Gel [Substance]
   770   C1514893:Resolved [Idea or Concept]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "transferred onto polyvinylidene difluoride membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "hybridized with VEGF specific probe."
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0182400:Probe [Medical Device]
   744   C0205369:Specific [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1704681:Probe [Gene or Genome]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2347609:Probe [Chemical Viewed Functionally]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3536729:Probe [Manufactured Object]
   735   C0014261:Endothelium, Vascular [Tissue]
   707 E C1706972:Blood Vessel Endothelium [Tissue]
Processing 00000000.tx.159: Amount of 18S and 28S was measured as loading control. 

Phrase: "Amount of 18S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "28S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552142:28s [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "measured as loading control."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   770   C0243148:control [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.160: Note that ectopic Id-1 expression in LNCaP cells leads to increased VEGF secretion, VEGF gene promoter activity as well as VEGF transcript.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that ectopic Id-1 expression in LNCaP cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1512167:Ectopic Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to increased VEGF secretion,"
Meta Candidates (Total=29; Excluded=1; Pruned=0; Remaining=28)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   767   C0333957:Increased growth [Pathologic Function]
   767   C0861064:increased lead [Finding]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0181586:leads [Medical Device]
   744   C0205217:Increased [Quantitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0442805:Increased [Functional Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1521761:Factor [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   735   C0014261:Endothelium, Vascular [Tissue]
   717   C0853362:blood lead [Laboratory Procedure]
   707 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "VEGF gene promoter activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   927   C1760030:vascular endothelial growth factor activity [Molecular Function]
   868   C1149472:growth factor activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   710   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "VEGF transcript."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.161: Inactivation of Id-1 leads to downregulation of VEGF in androgen-independent prostate cancer cells It was reported that both VEGF and Id-1 protein levels were high in an androgen-independent prostate cancer cell line DU145 (8,26). 

Phrase: "Inactivation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "leads to downregulation of VEGF"
Meta Candidates (Total=25; Excluded=1; Pruned=0; Remaining=24)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1160192:down-regulation of growth [Organism Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0013081:Down-Regulation [Cell Function,Molecular Function]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0220844:growth [Physiologic Function]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1521761:Factor [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   735   C0014261:Endothelium, Vascular [Tissue]
   717   C0853362:blood lead [Laboratory Procedure]
   707 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "in androgen-independent prostate cancer cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0334227:cancer cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771   C1654637:androgen independent prostate cancer [Neoplastic Process]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "It"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "both VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "and"

Phrase: "Id-1 protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "high in an androgen-independent prostate cancer cell line DU145"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205250:High [Qualitative Concept]
   739   C1299351:High [Qualitative Concept]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "(8,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.162: To further confirm the association between Id-1 and VEGF, we then transfected a vector containing the Si-Id-1 into DU145 cells to study if the downregulation of Id-1 could lead to inhibition of VEGF protein secretion. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the association between Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "VEGF,"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "we then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transfected"

Phrase: "a vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Si-Id-1 into DU145 cells to"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0309276:ID-1 [Pharmacologic Substance]
   750   C0007634:THE CELL [Cell]
           Cells
   744   C0600091:ID [Intellectual Product]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "if"

Phrase: "the downregulation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "could"

Phrase: "lead to inhibition of VEGF protein secretion."
Meta Candidates (Total=34; Excluded=0; Pruned=0; Remaining=34)
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   797   C2255852:inhibition of protein secretion [Cell Function]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   777   C1512280:Growth Factor Inhibition [Physiologic Function]
   777   C2249823:inhibition of growth [Organism Function]
   777   C2259158:inhibition of secretion [Cell Function]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1159339:Protein Secretion [Cell Function]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0220844:growth [Physiologic Function]
   739   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   739   C1521761:Factor [Functional Concept]
   739   C1522538:Lead [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2348269:Lead [Element, Ion, or Isotope]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   739   C3275067:LEAD [Therapeutic or Preventive Procedure]
   739   C3463820:Inhibition [Activity]
   724   C0014261:Endothelium, Vascular [Tissue]
   707   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C0853362:blood lead [Laboratory Procedure]
Processing 00000000.tx.163: As shown in Figure 2A, the stable transfectants (C1 to C4) showed decreased Id-1 protein expression (up to 80% decrease), compared with the parental DU145 cells and the vector control (ssCon) cells. 

Phrase: "As"

Phrase: "shown in Figure 2A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "the stable transfectants"

Phrase: "(C1 to C4)"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "decreased Id-1 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "up to 80% decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "compared with the parental DU145 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0030551:Parental [Family Group]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(ssCon"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: Using ELISA assay, we also found that downregulation of Id-1 was associated with decreased secretory VEGF protein in the cell culture medium (Figure 2B). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ELISA assay,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   708   C2717977:Enzyme Assay [Laboratory Procedure]

Phrase: "we also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that downregulation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "was"

Phrase: "associated with decreased secretory VEGF protein"
Meta Candidates (Total=30; Excluded=4; Pruned=0; Remaining=26)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2267119:Vascular Growth Decrease [Molecular Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   762   C0151686:Decreased growth [Pathologic Function]
   762   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C1327616:Secretory [Cell Function]
   742   C1521761:Factor [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   712   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708 E C0547047:Decrease [Quantitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "in the cell culture medium"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   901   C0007585:Cell Culture [Laboratory Procedure]
   901   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0007634:Cell [Cell]
   827   C0009458:Medium [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0439536:Medium [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705217:Medium [Substance]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3244283:medium [Intellectual Product]

Phrase: "(Figure 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.165: In addition, when we transfected the VEGF reporter construct into the Si-Id-1 and vector transfectants, decreased VEGF promoter activity was observed in the Si-Id-1 transfectants (up to 90% decrease) compared with the vector controls (Figure 2C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "when"

Phrase: "we"

Phrase: "transfected"

Phrase: "the VEGF reporter construct into the Si-Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "vector transfectants,"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "VEGF promoter activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   941   C1760030:vascular endothelial growth factor activity [Molecular Function]
   867   C1149472:growth factor activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "observed in the Si-Id-1 transfectants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0600091:ID [Intellectual Product]
   748   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "up to 90% decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: "compared with the vector controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Figure 2C"

Phrase: ")."
Processing 00000000.tx.166: In addition, mRNA of VEGF was also downregulated in the Si-Id-1 transfectant of DU145 cells (Figure 2D and E). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "mRNA of VEGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   716   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "downregulated in the Si-Id-1 transfectant of DU145 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0309276:ID-1 [Pharmacologic Substance]
   739   C0007634:Cells [Cell]
   739   C0600091:ID [Intellectual Product]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure"

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.167: These results further suggest the association between Id-1 and VEGF secretion in prostate cancer cells. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the association between Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "VEGF secretion in prostate cancer cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C1327616:Cell secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
Processing 00000000.tx.168: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.170: Suppression of VEGF expression in Si-Id-1 transfectants. 

Phrase: "Suppression of VEGF expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0151686:Growth suppression [Pathologic Function]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]

Phrase: "in Si-Id-1 transfectants."
Processing 00000000.tx.171: (A) Id-1 expression in stable DU145 transfectants expressing the Si-Id-1 (C1C4) demonstrated by western blotting. 

Phrase: "(A) Id-1 expression in stable DU145 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "expressing"

Phrase: "the Si-Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0309276:ID-1 [Pharmacologic Substance]
   827   C0600091:ID [Intellectual Product]

Phrase: "(C1C4"

Phrase: ")"

Phrase: "demonstrated by western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.172: (B) Secretory VEGF protein in the culture media of Si-Id-1 transfectants, the control (ssCon) and the parental cells examined by ELISA. 

Phrase: "(B) Secretory VEGF protein in the culture media"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0377800:b protein [Amino Acid, Peptide, or Protein,Receptor]
   754   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1336694:b-PROTEIN [Gene or Genome]
   754   C1455498:B-Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   704   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of Si-Id-1 transfectants,"

Phrase: "the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(ssCon"

Phrase: ")"

Phrase: "and"

Phrase: "the parental cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "examined by ELISA."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0332128:Examined [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.173: (C) VEGF promoter activity measured by luciferase assay. 

Phrase: "(C) VEGF promoter activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C1760030:vascular endothelial growth factor activity [Molecular Function]
   852   C1149472:growth factor activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   710   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "measured by luciferase assay."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0243073:assay [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.174: pGL-V109 and pRL-CMV-Luc vectors were co-transfected into DU145ssCon and the Si-Id-1 transfectants. 

Phrase: "pGL-V109"

Phrase: "and"

Phrase: "pRL-CMV-Luc vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "co-transfected into DU145ssCon"

Phrase: "and"

Phrase: "the Si-Id-1 transfectants."
Processing 00000000.tx.175: Luciferase activity was measured 48 h after transfection. 

Phrase: "Luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "48 h after transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.176: Results represent three independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.177: (D and E) mRNA level of VEGF in vector control and Si-Id-1 transfectant demonstrated by semi-quantitative RTPCR and northern blotting. 

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E) mRNA level of VEGF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Si-Id-1 transfectant"

Phrase: "demonstrated by semi-quantitative RTPCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0522525:Semi-quantitative [Quantitative Concept]
   806   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "northern blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005861:Northern Blotting [Molecular Biology Research Technique]
   983 E C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]
Processing 00000000.tx.178: Note that downregulation of Id-1 in DU145 cells leads to decreased VEGF secretion, promoter activity and mRNA level.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that downregulation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "in DU145 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "leads to decreased VEGF secretion,"
Meta Candidates (Total=31; Excluded=2; Pruned=0; Remaining=29)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2267119:Vascular Growth Decrease [Molecular Function]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   767   C0151686:Decreased growth [Pathologic Function]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C0181586:leads [Medical Device]
   744   C0205216:Decreased [Quantitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1521761:Factor [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   735   C0014261:Endothelium, Vascular [Tissue]
   717   C0853362:blood lead [Laboratory Procedure]
   711 E C0547047:Decrease [Quantitative Concept]
   707 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "mRNA level."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.179: Effect of secretory VEGF on angiogenesis in HUVECs Since the function of VEGF in tumour metastasis is mainly determined by its ability to promote new blood vessel formation, we investigated if the VEGF protein secreted by the Id-1 expressing cells had any effect on HUVECs in terms of proliferation and angiogenic ability by treating the HUVECs with cell culture media generated from Id-1 negative cells (LNCaP and pBabe) as well as from Id-1 positive cells (Id-1 clones as well as a pool of Id-1 transfectants) (Figure 3A). 

Phrase: "Effect of secretory VEGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "in HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "Since"

Phrase: "the function of VEGF"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   774   C0232337:Vascular function [Clinical Attribute]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   724 E C0005811:blood function [Organ or Tissue Function]

Phrase: "in tumour metastasis"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0027627:tumor metastasis [Neoplastic Process]
           Metastasis
  1000   C2939419:Tumor metastasis [Neoplastic Process]
   861   C2939420:metastasis [Neoplastic Process]
   789 E C0036525:Metastatic [Functional Concept]
   789 E C1522484:metastatic [Quantitative Concept]

Phrase: "is"

Phrase: "mainly"

Phrase: "determined by its ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "new blood vessel formation,"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   861   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   861   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   861   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   805 E C1558950:VASCULAR [Finding]
   805 E C1801960:Vascular [Qualitative Concept]
   777 E C0005767:Blood [Tissue]
   777 E C0005768:blood [Body Substance]
   777 E C0229664:Blood [Body Substance]
   777 E C0392895:Bloods [Population Group]
   756 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "if"

Phrase: "the VEGF protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   847   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "secreted by the Id-1 expressing cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C0600091:ID [Intellectual Product]
   748   C1327616:Secreted [Cell Function]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "any effect on HUVECs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
   703   C3179121:Human Umbilical Vein Endothelial Cells [Cell]

Phrase: "in terms of proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "angiogenic ability by treating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "the HUVECs with cell culture media"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   833   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   761   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   760   C0041637:Umbilical vein [Embryonic Structure]
   760   C0221313:Umbilical vein [Embryonic Structure]
   760   C0225336:Endothelial Cells [Cell]
   760   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   757   C0007585:cells culture [Laboratory Procedure]
   757   C0427861:Human cells [Laboratory or Test Result]
   741   C0007634:THE CELL [Cell]
           Cells
   741   C0226502:Medium vein [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   739   C0042449:Vein [Body Part, Organ, or Organ Component]
   739   C0086418:Human [Human]
   739   C1278960:Vein [Body Part, Organ, or Organ Component]
   739   C3282337:Cells [Cell]
   724   C1179027:Vein Endothelium [Tissue]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "generated from Id-1 negative cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0007634:Cells [Cell]
   753   C0205160:Negative [Qualitative Concept]
   753   C0600091:ID [Intellectual Product]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C3146294:Generated [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(LNCaP"

Phrase: "and"

Phrase: "pBabe"

Phrase: ")"

Phrase: "as well as from Id-1 positive cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C0309276:ID-1 [Pharmacologic Substance]
   770   C0439178:% positive cells [Quantitative Concept]
           % Positive
   767   C2347578:Cells/well [Quantitative Concept]
   744   C0007634:Cells [Cell]
   744   C0205170:Well [Qualitative Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C2825490:Positive [Qualitative Concept]
   744   C3146287:Well [Manufactured Object]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Id-1 clones"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   734   C0309276:ID-1 [Pharmacologic Substance]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "as well as"

Phrase: "a pool of Id-1 transfectants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: ")"

Phrase: "(Figure 3A"

Phrase: ")."
Processing 00000000.tx.180: We then studied the alterations of cell morphology, capillary tube formation and proliferation of endothelial cells. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the alterations of cell morphology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C1260954:Morphologic alteration [Anatomical Abnormality]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "capillary tube formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2752214:tube formation [Organ or Tissue Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0184108:capillary tube [Medical Device]

Phrase: "and"

Phrase: "proliferation of endothelial cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1655807:endothelial cell proliferation [Cell Function]
   802   C0596290:Cell Proliferation [Cell Function]
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.181: As shown in Figure 3B, after culturing the HUVECs in the medium of Id-1 transfectants for 48 h, these cells showed elongated morphology and the ability to form cellcell networking, which was also observed in the same cells treated with the recombinant human VEGF (rhVEGF, 20 ng/ml; equivalent to the lowest VEGF concentration produced in the Id-1 transfectants). 

Phrase: "As"

Phrase: "shown in Figure 3B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450365:3b [Intellectual Product]
   770   C1706097:3B [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "after"

Phrase: "culturing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "the HUVECs in the medium of Id-1 transfectants"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   802   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   766   C1179017:Endothelial cell of vein [Cell]
   750   C0041637:Umbilical vein [Embryonic Structure]
   750   C0221313:Umbilical vein [Embryonic Structure]
   750   C0225336:Endothelial Cells [Cell]
   750   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   749   C0226502:Medium vein [Body Part, Organ, or Organ Component]
   749   C0427861:Human cells [Laboratory or Test Result]
   738   C1179027:Endothelium of vein [Tissue]
           Vein Endothelium
   735   C0007634:Cells [Cell]
           THE CELL
   735   C0014257:Endothelial [Tissue]
   735   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   735   C0042449:Vein [Body Part, Organ, or Organ Component]
   735   C0086418:Human [Human]
   735   C1278960:Vein [Body Part, Organ, or Organ Component]
   735   C3282337:Cells [Cell]
   702 E C1269647:Cell [Cell]
   702 E C1704653:Cell [Medical Device]
   702 E C1948049:Cell [Spatial Concept]

Phrase: "for 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "elongated morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "cellcell networking,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1882071:networking [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]

Phrase: "which"

Phrase: "was"

Phrase: "also"

Phrase: "observed in the same cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0445247:Same [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the recombinant human VEGF"
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   849   C1171892:vascular endothelial growth factor, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   838   C1522575:Recombinant Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Vascular Endothelial Growth Factor
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1515377:Recombinant Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0086418:Human [Human]
   742   C0220844:growth [Physiologic Function]
   742   C1514798:recombinant [Organism]
   742   C1521761:Factor [Functional Concept]
   742   C1522326:Treated [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   708 E C1292734:TREAT [Functional Concept]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "(rhVEGF,"

Phrase: "20 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; equivalent to the lowest VEGF concentration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]

Phrase: "produced in the Id-1 transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0600091:ID [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.182: In contrast, the cells cultured in the RPMI medium, or media generated from LNCaP and pBabe cultures showed the typical round and scattered morphology. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in the RPMI medium,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "generated from LNCaP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "pBabe cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the typical round"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332490:Round [Spatial Concept]

Phrase: "and"

Phrase: "scattered morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.183: In addition, with the use of the culture medium from Id-1 transfectants the ability of HUVECs to form tube-like structures was enhanced by up to 3-fold. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "with the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "from Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "the ability of HUVECs to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "tube-like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "was"

Phrase: "enhanced by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2349975:Enhanced [Activity]

Phrase: "up to 3-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.184: This effect was similar to the one induced by similar concentrations of rhVEGF (Figure 3C and D). 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "similar to the one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "induced by similar concentrations of rhVEGF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0086045:Concentrations [Mental Process]
   753   C0205263:Induced [Functional Concept]
   753   C2348205:Similar [Qualitative Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Figure 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.185: Furthermore, the proliferation rate of the HUVECs grown in the media generated from Id-1 expressing cells was up to 3-fold higher than the cells cultured in the media from LNCaP and pBabe cells (Figure 3E). 

Phrase: "Furthermore,"

Phrase: "the proliferation rate of the HUVECs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]

Phrase: "grown in the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "generated from Id-1 expressing cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0007634:Cells [Cell]
   753   C0600091:ID [Intellectual Product]
   753   C3146294:Generated [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "was up to 3-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332462:Fold [Spatial Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than the cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "cultured in the media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737   C2242979:Culture [Laboratory Procedure]
   737 E C3244283:medium [Intellectual Product]

Phrase: "from LNCaP"

Phrase: "and"

Phrase: "pBabe cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 3E"

Phrase: ")."
Processing 00000000.tx.186: Taken together, these results showed that the secretory VEGF by the Id-1 expressing LNCaP cells was able to promote proliferation and angiogenesis in HUVECs. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the secretory VEGF by the Id-1 expressing LNCaP cells"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   784   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   766   C0016026:Endothelial Cell Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C1333536:ENDOTHELIAL CELL GROWTH FACTOR [Gene or Genome]
   763   C1257792:Vascular Endothelial Cells [Cell]
   750   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C0007595:cells growth [Cell Function]
   749   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   749   C0225336:Endothelial Cells [Cell]
   735   C0005847:vascular [Body Part, Organ, or Organ Component]
   735   C0014257:Endothelial [Tissue]
   735   C0018270:'growth' NOS [Organism Function]
   735   C0220844:growth [Physiologic Function]
   735   C1521761:Factor [Functional Concept]
   735   C1558950:VASCULAR [Finding]
   735   C1621966:Growth [Organ or Tissue Function]
   735   C1801960:Vascular [Qualitative Concept]
   735   C2827422:Factor [Conceptual Entity]
   735   C2911660:Growth [Activity]
   714   C0014261:Endothelium, Vascular [Tissue]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "angiogenesis in HUVECs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302600:Angiogenesis [Organ or Tissue Function]
   748   C1519670:angiogenesis [Neoplastic Process]
   731   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
Processing 00000000.tx.187: View larger version (47K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.188: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.189: Id-1-induced angiogenic effect on HUVECs. 

Phrase: "Id-1-induced angiogenic effect on HUVECs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.190: (A) Id-1 expression in LNCaP, vector control, Id-1 transfected clone and the pool of Id-1 transfectants demonstrated by western blotting. 

Phrase: "(A) Id-1 expression in LNCaP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "vector control,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "Id-1 transfected clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "and"

Phrase: "the pool of Id-1 transfectants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "demonstrated by western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.191: (B) Morphological changes in the HUVECs cultured in the growth media of LNCaP, pBabe and Id-1 transfectants (C3, C4 and pool of transfectants). 

Phrase: "(B) Morphological changes in the HUVECs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   739   C0543482:morphological [Spatial Concept]
   706 E C1705241:Change [Quantitative Concept]
   705   C0243091:cell morphology [Qualitative Concept]
   705   C1521816:Cell morphology [Clinical Attribute]
   705   C2700385:Cell Morphology [Biomedical Occupation or Discipline]

Phrase: "cultured in the growth media of LNCaP,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
           Culture Media
   748   C0009458:Media [Intellectual Product]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0162867:Media [Tissue]
   748   C0220844:growth [Physiologic Function]
   748   C1254021:Media [Tissue]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714   C2242979:Culture [Laboratory Procedure]
   714 E C3244283:medium [Intellectual Product]

Phrase: "pBabe"

Phrase: "and"

Phrase: "Id-1 transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "(C3,"

Phrase: "C4"

Phrase: "and"

Phrase: "pool of transfectants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0337051:Pool [Geographic Area]
   790   C1509144:pool [Clinical Attribute]
   790   C2349200:Pool [Functional Concept]

Phrase: ")."
Processing 00000000.tx.192: (C and D) Tube formation ability of HUVECs cultured in growth media generated from LNCaP cells expressing high and low levels of Id-1. 

Phrase: "(C"

Phrase: "and"

Phrase: "D)"

Phrase: "Tube formation ability of HUVECs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in growth media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "generated from LNCaP cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3146294:Generated [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "low levels of Id-1."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.193: (E) BrdU incorporation rates of HUVECs cultured in different growth media. 

Phrase: "(E) BrdU incorporation rates of HUVECs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C0871208:Rate [Activity]
   706   C1521828:Rate [Quantitative Concept]

Phrase: "cultured in different growth media."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   806   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
           Culture Media
   760   C0009458:Media [Intellectual Product]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0162867:Media [Tissue]
   760   C0220844:growth [Physiologic Function]
   760   C1254021:Media [Tissue]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1705242:Different [Qualitative Concept]
   760   C2911660:Growth [Activity]
   756   C2752783:differential growth [Organism Function]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726   C2242979:Culture [Laboratory Procedure]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.194: The RPMI alone and rhVEGF (20 ng/ml) treated HUVECs were used as negative and positive controls, respectively. 

Phrase: "The RPMI"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "rhVEGF"

Phrase: "(20 ng/ml) treated HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   873   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   842   C0427861:Human cells [Laboratory or Test Result]
   807   C0041637:Umbilical vein [Embryonic Structure]
   807   C0221313:Umbilical vein [Embryonic Structure]
   807   C0225336:Endothelial Cells [Cell]
   807   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   791   C0007634:Cells [Cell]
   791   C0014257:Endothelial [Tissue]
   791   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   791   C0042449:Vein [Body Part, Organ, or Organ Component]
   791   C0086418:Human [Human]
   791   C1278960:Vein [Body Part, Organ, or Organ Component]
   791   C3282337:Cells [Cell]
   772   C1179027:Vein Endothelium [Tissue]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used as negative"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0205160:Negative [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1513916:Negative [Finding]
   790   C2825415:Negative [Conceptual Entity]
   790   C2825491:Negative [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "positive controls,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.195: Cells were cultured in different culture media for 24 h and the morphological changes, capillary tube formation ability and BrdU incorporation rate were studied. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in different culture media"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   781   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   760   C1705242:Different [Qualitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726   C0683975:cultural differences [Qualitative Concept]
   726 E C1705217:Medium [Substance]
   726   C2242979:Culture [Laboratory Procedure]
   726 E C3244283:medium [Intellectual Product]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the morphological changes,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   933   C1260954:Morphologic change [Anatomical Abnormality]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0543482:morphological [Spatial Concept]
   827 E C1705241:Change [Quantitative Concept]
   789 E C0332437:Morphology [Qualitative Concept]
   789 E C0700329:Morphology, NOS [Finding]
   789 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "capillary tube formation ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0085732:Ability [Organism Attribute]
   741 E C1299581:Able [Finding]

Phrase: "and"

Phrase: "BrdU incorporation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.196: Note that the growth media from Id-1 expressing LNCaP cells induced proliferation and angiogenesis in HUVECs at similar levels to that of rhVEGF. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the growth media from Id-1 expressing LNCaP cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   762   C0007595:cells growth [Cell Function]
   742   C0009458:Media [Intellectual Product]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0162867:Media [Tissue]
   742   C0220844:growth [Physiologic Function]
   742   C1254021:Media [Tissue]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2911660:Growth [Activity]
   708 E C0439536:Medium [Quantitative Concept]
   708 E C1705217:Medium [Substance]
   708 E C3244283:medium [Intellectual Product]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "angiogenesis in HUVECs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302600:Angiogenesis [Organ or Tissue Function]
   748   C1519670:angiogenesis [Neoplastic Process]
   731   C3179121:Human Umbilical Vein Endothelial Cells [Cell]

Phrase: "at similar levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "to that"

Phrase: "of rhVEGF."
Processing 00000000.tx.197: See online Supplementary material for a colour version of this figure.  

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "online Supplementary material for a colour version of this figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2936424:Supplementary Material [Intellectual Product]
   739   C0520510:Material [Substance]
Processing 00000000.tx.198: Effect of VEGF receptor Flk-1 kinase inhibitor, SU1498 and VEGF neutralizing antibody, on Id-1-induced angiogenesis To further confirm that the Id-1-induced VEGF secretion was responsible for the angiogenic effect on HUVECs, we treated the prostate cancer cell culture media with an inhibitor of the VEGF receptor Flk-1, SU1498. 

Phrase: "Effect of VEGF receptor Flk-1 kinase inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "SU1498"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1436360:SU1498 [Organic Chemical]

Phrase: "and"

Phrase: "VEGF neutralizing antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   876   C0443907:Endothelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0475463:Neutralising antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "on Id-1-induced angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0302600:Angiogenesis [Organ or Tissue Function]
   812   C1519670:angiogenesis [Neoplastic Process]

Phrase: "To further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the Id-1-induced VEGF secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0036536:secretion [Biologic Function]
   793   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "responsible for the angiogenic effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "on HUVECs,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "the prostate cancer cell culture media with an inhibitor"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   790   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   764   C0007585:Cell Culture [Laboratory Procedure]
   764   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   764   C0334227:Cancer Cell [Cell]
   762   C0007634:THE CELL [Cell]
           Cell
   742   C0009458:Media [Intellectual Product]
   742   C0010453:Culture [Idea or Concept]
   742   C0162867:Media [Tissue]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C1254021:Media [Tissue]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2242979:Culture [Laboratory Procedure]
   708 E C0439536:Medium [Quantitative Concept]
   708 E C1705217:Medium [Substance]
   708 E C3244283:medium [Intellectual Product]

Phrase: "of the VEGF receptor Flk-1,"
Meta Candidates (Total=29; Excluded=3; Pruned=0; Remaining=26)
   947   C0378516:Vascular Endothelial Growth Factor Receptor-1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
           Vascular Endothelial Growth Factor Receptor
   947   C0812298:VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 [Gene or Genome]
   913   C0148199:Vascular Endothelial Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   913   C1334306:VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   877   C0059279:Endothelial Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   877   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   845   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   845   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1504624:FLK-1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   795   C0005847:vascular [Body Part, Organ, or Organ Component]
   795   C0014257:Endothelial [Tissue]
   795   C0018270:'growth' NOS [Organism Function]
   795   C0220844:growth [Physiologic Function]
   795   C0349396:FLK [Geographic Area]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0806492:FLK [Amino Acid, Peptide, or Protein]
   795   C1521761:Factor [Functional Concept]
   795   C1558950:VASCULAR [Finding]
   795   C1621966:Growth [Organ or Tissue Function]
   795   C1801960:Vascular [Qualitative Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C2911660:Growth [Activity]
   782   C0014261:Endothelium, Vascular [Tissue]
   755 E C1706972:Blood Vessel Endothelium [Tissue]
   740 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   740 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "SU1498."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1436360:SU1498 [Organic Chemical]
Processing 00000000.tx.199: As shown in Figure 4, the addition of SU1498 (40 M) in the culture medium of Id-1 transfectants or in the medium that is supplemented with hrVEGF led to the disappearance of the tube-like structure (Figure 4A and B) and decrease in the BrdU incorporation rate (Figure 4C) in HUVECs without the cell viability being affected (Figure 4D). 

Phrase: "As"

Phrase: "shown in Figure 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "the addition of SU1498"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M) in the culture medium of Id-1 transfectants"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   764   C0309276:ID-1 [Pharmacologic Substance]
   742   C0009458:Medium [Intellectual Product]
   742   C0010453:Culture [Idea or Concept]
   742   C0220814:culture [Functional Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0439536:Medium [Quantitative Concept]
   742   C0441923:M+ [Intellectual Product]
   742   C0600091:ID [Intellectual Product]
   742   C1705217:Medium [Substance]
   742   C2242979:Culture [Laboratory Procedure]
   742   C3244283:medium [Intellectual Product]

Phrase: "or in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "supplemented with hrVEGF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "led to the disappearance of the tube-like structure"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   742   C0175730:Tube [Medical Device]
   742   C0678594:Structure [Spatial Concept]
   742   C1547937:Tube NOS [Intellectual Product]
   742   C1561954:tube [Conceptual Entity]
   742   C1704730:TUBE [Medical Device]
   742   C1708698:LED [Manufactured Object]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "decrease in the BrdU incorporation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "(Figure 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "in HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "without the cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "being"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "(Figure"

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.200: The same effect was observed when the VEGF neutralizing antibody (+neut Ab) was added into the prostate cancer cell culture media, indicating that the inhibition of VEGF function reverses the angiogenic effect induced by Id-1 in prostate cancer cells. 

Phrase: "The same effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the VEGF neutralizing antibody (+neut Ab)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   876   C0443907:Endothelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0475463:Neutralising antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "added into the prostate cancer cell culture media,"
Meta Candidates (Total=29; Excluded=4; Pruned=0; Remaining=25)
   800   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   770   C0007585:Cell Culture [Laboratory Procedure]
   770   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0334227:Cancer Cell [Cell]
   770   C0376358:Prostate Cancer [Neoplastic Process]
   770   C0600139:Prostate Cancer [Neoplastic Process]
   770   C2984325:Prostate cancer [Functional Concept]
   770   C3541264:Prostate Cancer [Intellectual Product]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0007634:Cell [Cell]
   744   C0009458:Media [Intellectual Product]
   744   C0010453:Culture [Idea or Concept]
   744   C0033572:Prostate [Body Part, Organ, or Organ Component]
   744   C0162867:Media [Tissue]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0998265:Cancer [Eukaryote]
   744   C1254021:Media [Tissue]
   744   C1269647:Cell [Cell]
   744   C1278980:Prostate [Body Part, Organ, or Organ Component]
   744   C1306459:Cancer [Finding]
   744   C1524062:Added [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2242979:Culture [Laboratory Procedure]
   711 E C0439536:Medium [Quantitative Concept]
   711 E C1705217:Medium [Substance]
   711 E C1883712:Add [Functional Concept]
   711 E C3244283:medium [Intellectual Product]

Phrase: "indicating"

Phrase: "that"

Phrase: "the inhibition of VEGF function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C1512280:Growth Factor Inhibition [Physiologic Function]
   793   C2249823:inhibition of growth [Organism Function]
   767   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   744   C0021467:Inhibition [Mental Process]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the angiogenic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "induced by Id-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0309276:ID-1 [Pharmacologic Substance]
   770   C0205263:Induced [Functional Concept]
   770   C0600091:ID [Intellectual Product]

Phrase: "in prostate cancer cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]
Processing 00000000.tx.201: View larger version (42K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.202: 4. 

Phrase: "4."
Processing 00000000.tx.203: Effect of Flk-1 inhibitor on the Id-1-induced angiogenesis in HUVECs. 

Phrase: "Effect of Flk-1 inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the Id-1-induced angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0302600:Angiogenesis [Organ or Tissue Function]
   812   C1519670:angiogenesis [Neoplastic Process]

Phrase: "in HUVECs."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.204: (AC) Treatment of HUVECs with SU1498 (40 M), an Flk-1 inhibitor or with VEGF neutralizing antibody, leads to suppression of capillary tube formation ability and BrdU incorporation rate induced by Id-1 expression in LNCaP cells. 

Phrase: "(AC) Treatment of HUVECs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]
   703   C3179121:Human Umbilical Vein Endothelial Cells [Cell]

Phrase: "with SU1498"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1436360:SU1498 [Organic Chemical]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)"

Phrase: ","

Phrase: "an Flk-1 inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C1504624:FLK-1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "or with VEGF neutralizing antibody,"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   833   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   800   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0475463:Neutralising antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   767   C0443907:Endothelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0014257:Endothelial [Tissue]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0220844:growth [Physiologic Function]
   744   C1521761:Factor [Functional Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   735   C0014261:Endothelium, Vascular [Tissue]
   707 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "leads to suppression of capillary tube formation ability"
Meta Candidates (Total=24; Excluded=1; Pruned=0; Remaining=23)
   770   C0184108:capillary tube [Medical Device]
   770   C2752214:tube formation [Organ or Tissue Function]
   767 E C1707263:Tube Capillary [Medical Device]
   744   C0006901:Capillary [Body Part, Organ, or Organ Component]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0085732:Ability [Organism Attribute]
   744   C0175730:Tube [Medical Device]
   744   C0181586:leads [Medical Device]
   744   C0220781:formation [Biologic Function]
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0439634:formation [Spatial Concept]
   744   C0728721:suppression [Mental Process]
   744   C0935624:Capillary [Body Part, Organ, or Organ Component]
   744   C1280521:Capillary [Body Part, Organ, or Organ Component]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1547937:Tube NOS [Intellectual Product]
   744   C1561954:tube [Conceptual Entity]
   744   C1704730:TUBE [Medical Device]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "BrdU incorporation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "induced by Id-1 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0309276:ID-1 [Pharmacologic Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205263:Induced [Functional Concept]
   760   C0600091:ID [Intellectual Product]

Phrase: "in LNCaP cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.205: Detailed experimental procedures are as described in Figure 3. 

Phrase: "Detailed experimental procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "are"

Phrase: "as"

Phrase: "described in Figure 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.206: (D) DAPI staining of apoptotic cells in SU1498-treated or untreated HUVECs. 

Phrase: "("

Phrase: "D)"

Phrase: "DAPI staining of apoptotic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "in SU1498-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "untreated HUVECs."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   947   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   876   C0427861:Human cells [Laboratory or Test Result]
   827   C0041637:Umbilical vein [Embryonic Structure]
   827   C0221313:Umbilical vein [Embryonic Structure]
   827   C0225336:Endothelial Cells [Cell]
   827   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0014257:Endothelial [Tissue]
   799   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   799   C0042449:Vein [Body Part, Organ, or Organ Component]
   799   C0086418:Human [Human]
   799   C1278960:Vein [Body Part, Organ, or Organ Component]
   799   C3282337:Cells [Cell]
   791   C1179027:Vein Endothelium [Tissue]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.207: See online Supplementary material for a colour version of this figure.  

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "online Supplementary material for a colour version of this figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2936424:Supplementary Material [Intellectual Product]
   739   C0520510:Material [Substance]
Processing 00000000.tx.208: Correlation of Id-1 and VEGF expression in human prostate cancer xenografts To further confirm the association between Id-1 and VEGF in prostate cancer, we studied the expression of Id-1 and VEGF in human xenografts, CWR22 and CWR22R, which are recently established prostate cancer models and have been shown to mimic the clinical conditions in recurrent prostate cancer patients (24,25). 

Phrase: "Correlation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "VEGF expression in human prostate cancer xenografts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "To further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the association between Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "VEGF in prostate cancer,"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   853   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0014257:Endothelial [Tissue]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1801960:Vascular [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   746   C1655210:blood vessel cancer [Neoplastic Process]
   743   C0014261:Endothelium, Vascular [Tissue]
   724 E C0348393:blood cancer [Neoplastic Process]
   724 E C0376545:blood cancer [Neoplastic Process]
   715 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "VEGF in human xenografts,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   879   C1171892:vascular endothelial growth factor, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0014257:Endothelial [Tissue]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1801960:Vascular [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   743   C0014261:Endothelium, Vascular [Tissue]
   715 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "CWR22"

Phrase: "and"

Phrase: "CWR22R,"

Phrase: "which"

Phrase: "are"

Phrase: "recently established prostate cancer models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C1516211:Cancer Model [Experimental Model of Disease]
   804   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "the clinical conditions in recurrent prostate cancer patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205210:Clinical [Qualitative Concept]
   734   C0683521:condition patient [Finding]
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.209: Previously, we found that CWR22R, the androgen-independent derivative of the original androgen-dependent CWR22 xenograft, had much higher levels of Id-1 expression (14). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that CWR22R,"

Phrase: "the androgen-independent derivative of the original androgen-dependent CWR22 xenograft,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1527240:Derivative [Functional Concept]

Phrase: "had"

Phrase: "much higher levels of Id-1 expression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0456947:Level 1 [Intellectual Product]
   757   C3244092:expression level [Idea or Concept]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.210: In this study, using immunohistochemistry, we observed (Figure 5A) that the increased Id-1 protein expression in the CWR22R tumour (panel 2) was associated with higher levels of VEGF expression (panel 4) when compared with the CWR22 tumour specimens (panels 1 and 3). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Figure 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "that"

Phrase: "the increased Id-1 protein expression in the CWR22R tumour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1171362:protein expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(panel 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "associated with higher levels of VEGF expression"
Meta Candidates (Total=29; Excluded=5; Pruned=0; Remaining=24)
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   741   C3244092:expression level [Idea or Concept]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0220844:growth [Physiologic Function]
   739   C0441889:Levels [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   724   C0014261:Endothelium, Vascular [Tissue]
   716   C0424639:growth height [Finding]
   706   C0205250:High [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C0750490:Associate [Idea or Concept]
   706   C1299351:High [Qualitative Concept]
   706 E C1547707:Level [Geographic Area]
   706 E C1706221:Associate [Professional or Occupational Group]
   706   C2700149:HIGH [Intellectual Product]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(panel 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "when"

Phrase: "compared with the CWR22 tumour specimens"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0027651:Tumor [Neoplastic Process]
   753   C0370003:specimens [Substance]
   753   C1578706:Tumor [Intellectual Product]
   753   C1707455:Compared [Activity]
   753   C3273930:Tumor [Finding]
   719 E C2347026:Specimen [Conceptual Entity]

Phrase: "(panels 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.211: Recently, it was reported that increased Id-1 mRNA expression was found in prostate cancer tissues after the hormone ablation treatment (27). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that increased Id-1 mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1515670:mRNA Expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "found in prostate cancer tissues"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0376358:Prostate Cancer [Neoplastic Process]
   806   C0600139:Prostate Cancer [Neoplastic Process]
   806   C2984325:Prostate cancer [Functional Concept]
   806   C3541264:Prostate Cancer [Intellectual Product]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0033572:Prostate [Body Part, Organ, or Organ Component]
   760   C0040300:Tissues [Tissue]
   760   C0150312:Found [Quantitative Concept]
   760   C0998265:Cancer [Eukaryote]
   760   C1278980:Prostate [Body Part, Organ, or Organ Component]
   760   C1306459:Cancer [Finding]
   726 E C0243095:Find [Finding]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "after the hormone ablation treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0279025:hormone treatment [Therapeutic or Preventive Procedure]
   913   C2966671:Hormone treatment [Clinical Attribute]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.212: In this study, using the CWR22 nude mice model, we investigated whether the Id-1 protein expression in the prostate cancer cells was associated with VEGF levels, before and after the surgical castration. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the CWR22 nude mice model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the Id-1 protein expression in the prostate cancer cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1171362:protein expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "associated with VEGF levels,"
Meta Candidates (Total=24; Excluded=6; Pruned=0; Remaining=18)
   853   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0014257:Endothelial [Tissue]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0441889:Levels [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1801960:Vascular [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   743   C0014261:Endothelium, Vascular [Tissue]
   715 E C1706972:Blood Vessel Endothelium [Tissue]
   714 E C0456079:Level [Classification]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "before"

Phrase: "and after the surgical castration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007344:Surgical Castration [Therapeutic or Preventive Procedure]
           Castration
   760   C0029189:Castration [Therapeutic or Preventive Procedure]
   760   C0543467:Surgical [Health Care Activity]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.213: As shown in Figure 5B, Id-1 protein expression was notably increased in the CWR22 xenograft 24 h after castration of the nude mice compared with the tumours generated from uncastrated mice (panels 1 and 2). 

Phrase: "As"

Phrase: "shown in Figure 5B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "Id-1 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "notably"

Phrase: "increased in the CWR22 xenograft 24 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0205217:Increased [Quantitative Concept]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0442805:Increased [Functional Concept]
   748   C0520484:xenograft [Therapeutic or Preventive Procedure]
   748   C0522537:Xenograft [Biomedical or Dental Material]
   748   C0564385:/h [Quantitative Concept]

Phrase: "after castration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007344:Castration [Therapeutic or Preventive Procedure]
  1000   C0029189:Castration [Therapeutic or Preventive Procedure]

Phrase: "of the nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025932:Mice, Nude [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C1425014:NUDE [Gene or Genome]

Phrase: "compared with the tumours"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027651:tumours [Neoplastic Process]
   770   C1707455:Compared [Activity]

Phrase: "generated from uncastrated mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C3146294:Generated [Activity]

Phrase: "(panels 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.214: We also found that the increased Id-1 expression in the tumours from castrated mice was associated with high levels of VEGF protein expression (panel 4) compared with the tumours from uncastrated mice (panel 3). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the increased Id-1 expression in the tumours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from castrated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "associated with high levels of VEGF protein expression"
Meta Candidates (Total=32; Excluded=5; Pruned=0; Remaining=27)
   797   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   775   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   756   C1171362:protein expression [Genetic Function]
   754   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0014257:Endothelial [Tissue]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205250:High [Qualitative Concept]
   738   C0220844:growth [Physiologic Function]
   738   C0441889:Levels [Qualitative Concept]
   738   C1299351:High [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1558950:VASCULAR [Finding]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1801960:Vascular [Qualitative Concept]
   738   C2700149:HIGH [Intellectual Product]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   737   C0428479:Protein level [Laboratory or Test Result]
   737   C3244092:expression level [Idea or Concept]
   720   C0014261:Endothelium, Vascular [Tissue]
   704   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   704 E C0456079:Level [Classification]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1547707:Level [Geographic Area]
   704 E C1706221:Associate [Professional or Occupational Group]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "(panel 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "compared with the tumours"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027651:tumours [Neoplastic Process]
   770   C1707455:Compared [Activity]

Phrase: "from uncastrated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(panel 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.215: These findings confirm the results generated from prostate cancer cell lines and further suggest the association between Id-1 and VEGF. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "generated from prostate cancer cell lines"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   790   C0007600:Cell lines [Cell]
   790   C0334227:Cancer Cell [Cell]
   790   C0376358:Prostate Cancer [Neoplastic Process]
   790   C0600139:Prostate Cancer [Neoplastic Process]
   790   C2984325:Prostate cancer [Functional Concept]
   790   C3541264:Prostate Cancer [Intellectual Product]
   753   C0006826:Cancer [Neoplastic Process]
   753   C0007634:Cell [Cell]
   753   C0033572:Prostate [Body Part, Organ, or Organ Component]
   753   C0205132:lines [Spatial Concept]
   753   C0998265:Cancer [Eukaryote]
   753   C1269647:Cell [Cell]
   753   C1278980:Prostate [Body Part, Organ, or Organ Component]
   753   C1306459:Cancer [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3146294:Generated [Activity]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the association between Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "VEGF."
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.216: View larger version (112K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(112K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.217: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.218: Immunohistochemical staining of Id-1 and VEGF proteins in human prostate xenografts CWR22 and CWR22R. 

Phrase: "Immunohistochemical staining of Id-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1441616:Immunohistochemical [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "VEGF proteins in human prostate xenografts CWR22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C0005832:Blood Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "CWR22R."
Processing 00000000.tx.219: CWR22 and CWR22R xenografts were propagated in nude mice and processed as described in Materials and methods. 

Phrase: "CWR22"

Phrase: "and"

Phrase: "CWR22R xenografts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520484:xenografts [Therapeutic or Preventive Procedure]
   861   C0522537:Xenografts [Biomedical or Dental Material]

Phrase: "were"

Phrase: "propagated in nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0025932:Mice, Nude [Mammal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1425014:NUDE [Gene or Genome]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.220: (A) Differential expression of Id-1 and VEGF in CWR22 and CWR22R xenografts. 

Phrase: "(A) Differential expression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "VEGF in CWR22"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   882   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   754   C0014261:Endothelium, Vascular [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0014257:Endothelial [Tissue]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C1801960:Vascular [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   726 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "and"

Phrase: "CWR22R xenografts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520484:xenografts [Therapeutic or Preventive Procedure]
   861   C0522537:Xenografts [Biomedical or Dental Material]
Processing 00000000.tx.221: (B) Differential Id-1 and VEGF expression in CWR22 xenografts before and after castration. 

Phrase: "(B) Differential Id-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0309276:ID-1 [Pharmacologic Substance]
   812   C0443199:Differential [Qualitative Concept]
   812   C0600091:ID [Intellectual Product]
   812   C1705242:Differential [Qualitative Concept]
   812   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "VEGF expression in CWR22 xenografts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "before"

Phrase: "and after castration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007344:Castration [Therapeutic or Preventive Procedure]
   790   C0029189:Castration [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.222: Note that increased Id-1 expression is associated with high levels of VEGF protein in human prostate cancer xenografts. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that increased Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with high levels of VEGF protein"
Meta Candidates (Total=29; Excluded=5; Pruned=0; Remaining=24)
   806   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   782   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0014257:Endothelial [Tissue]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205250:High [Qualitative Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0441889:Levels [Qualitative Concept]
   739   C1299351:High [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1801960:Vascular [Qualitative Concept]
   739   C2700149:HIGH [Intellectual Product]
   739   C2827422:Factor [Conceptual Entity]
   739   C2911660:Growth [Activity]
   724   C0014261:Endothelium, Vascular [Tissue]
   707   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   706 E C0456079:Level [Classification]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1547707:Level [Geographic Area]
   706 E C1706221:Associate [Professional or Occupational Group]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "in human prostate cancer xenografts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520484:xenografts [Therapeutic or Preventive Procedure]
   812   C0522537:Xenografts [Biomedical or Dental Material]
Processing 00000000.tx.223: Results represent xenografts from five nude mice. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "xenografts from five nude mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520484:xenografts [Therapeutic or Preventive Procedure]
   760   C0522537:Xenografts [Biomedical or Dental Material]
Processing 00000000.tx.224: See online Supplementary material for a colour version of this figure.   

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "online Supplementary material for a colour version of this figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2936424:Supplementary Material [Intellectual Product]
   739   C0520510:Material [Substance]
Processing 00000000.tx.225: Discussion Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Recently, more and more evidence supports the role of Id-1 as an oncogene which promotes tumourigenesis through inactivation of tumour suppressing (i.e. p16INK4a/pRB) (2) and activation of growth promoting (i.e. MAPK) (15) pathways. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "and"

Phrase: "more evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the role of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "as an oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "which"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "tumourigenesis through inactivation of tumour suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0007621:Tumorigenesis [Neoplastic Process]
   753   C0596263:Tumorigenesis [Neoplastic Process]

Phrase: "(i.e. p16INK4a/pRB) (2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0080113:pRb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "activation of growth promoting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   909   C2249824:activation of growth [Organism Function]
   770   C1879547:Activation [Activity]

Phrase: "(i.e. MAPK"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   876   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "(15"

Phrase: ")"

Phrase: "pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.226: However, the molecular basis responsible for the function of Id-1 in tumour progression is not clear. 

Phrase: "However,"

Phrase: "the molecular basis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1853126:MOLECULAR BASIS [Idea or Concept]
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "responsible for the function of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "in tumour progression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178874:Tumor Progression [Neoplastic Process]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.227: In this study, we have demonstrated that increased Id-1 expression leads to increased VEGF protein secretion through activation of the VEGF gene (Figures 1 and 2). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that increased Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to increased VEGF protein secretion"
Meta Candidates (Total=32; Excluded=1; Pruned=0; Remaining=31)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   762   C0333957:Increased growth [Pathologic Function]
   762   C0861064:increased lead [Finding]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0181586:leads [Medical Device]
   742   C0205217:Increased [Quantitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0442805:Increased [Functional Concept]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1521761:Factor [Functional Concept]
   742   C1522538:Lead [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]
   729   C0014261:Endothelium, Vascular [Tissue]
   712   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   712   C0853362:blood lead [Laboratory Procedure]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "through activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the VEGF gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0812325:Growth Factor Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "(Figures 1"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.228: The active form of VEGF in turn stimulates endothelial cell proliferation and promotes blood vessel formation (Figure 3). 

Phrase: "The active form of VEGF in turn"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "stimulates"

Phrase: "endothelial cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1655807:endothelial cell proliferation [Cell Function]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0225336:Endothelial cell [Cell]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "blood vessel formation"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   901   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   901   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   901   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   845 E C1558950:VASCULAR [Finding]
   845 E C1801960:Vascular [Qualitative Concept]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   817 E C0005767:Blood [Tissue]
   817 E C0005768:blood [Body Substance]
   817 E C0229664:Blood [Body Substance]
   817 E C0392895:Bloods [Population Group]
   795 E C0333275:Bloody [Qualitative Concept]
   771 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(Figure 3"

Phrase: ")."
Processing 00000000.tx.229: The association between Id-1 and VEGF was also confirmed on prostate cancer xenografts, the increased Id-1 expression was correlated with the upregulation of VEGF in nude mice (Figure 5). 

Phrase: "The association between Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "was"

Phrase: "also"

Phrase: "confirmed on prostate cancer xenografts,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   806   C0376358:Prostate Cancer [Neoplastic Process]
   806   C0600139:Prostate Cancer [Neoplastic Process]
   806   C2984325:Prostate cancer [Functional Concept]
   806   C3541264:Prostate Cancer [Intellectual Product]
   797   C1271092:Cancer confirmed [Finding]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0033572:Prostate [Body Part, Organ, or Organ Component]
   760   C0520484:xenografts [Therapeutic or Preventive Procedure]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0522537:Xenografts [Biomedical or Dental Material]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0998265:Cancer [Eukaryote]
   760   C1278980:Prostate [Body Part, Organ, or Organ Component]
   760   C1306459:Cancer [Finding]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "the increased Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "correlated with the upregulation of VEGF"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1160196:up-regulation of growth [Organism Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0041904:Up-Regulation [Cell Function,Molecular Function]
   742   C0162493:Up-Regulation [Genetic Function]
   742   C0220844:growth [Physiologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1707520:Correlated [Qualitative Concept]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "in nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025932:Mice, Nude [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C1425014:NUDE [Gene or Genome]

Phrase: "(Figure 5"

Phrase: ")."
Processing 00000000.tx.230: Our results provide a novel molecular basis for the metastatic progression of prostate cancer and indicate that inactivation of Id-1 may be a new strategy in the treatment of metastatic prostate cancer through suppression of tumour angiogenesis. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a novel molecular basis for the metastatic progression of prostate cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1853126:MOLECULAR BASIS [Idea or Concept]
   738   C1527178:Basis [Functional Concept]
   738   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "indicate"

Phrase: "that inactivation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be"

Phrase: "a new strategy in the treatment of metastatic prostate cancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0679199:strategy [Mental Process]

Phrase: "through suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0221103:Suppression [Pathologic Function]
  1000   C0301625:Suppression [Organism Function]
  1000   C0439181:% suppression [Quantitative Concept]
  1000   C0728721:suppression [Mental Process]

Phrase: "of tumour angiogenesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519670:Tumor Angiogenesis [Neoplastic Process]
           angiogenesis
   861   C0027651:Tumor [Neoplastic Process]
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
Processing 00000000.tx.231: Previously, impaired angiogenesis has been reported in Id-1 deficient mice as well as breast cancer xenografts (1618). 

Phrase: "Previously,"

Phrase: "impaired angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "has"

Phrase: "been"

Phrase: "reported in Id-1 deficient mice"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0011155:Deficient [Functional Concept]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0600091:ID [Intellectual Product]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1636779:% deficient [Quantitative Concept]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "as well as"

Phrase: "breast cancer xenografts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0520484:xenografts [Therapeutic or Preventive Procedure]
   827   C0522537:Xenografts [Biomedical or Dental Material]
   734   C0006142:Breast Cancer [Neoplastic Process]
   734   C0678222:Breast Cancer [Neoplastic Process]

Phrase: "(1618"

Phrase: ")."
Processing 00000000.tx.232: However, the present study is the first to demonstrate the direct correlation of Id-1 with VEGF-induced angiogenesis in human cancer cells. 

Phrase: "However,"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the direct correlation of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "with VEGF-induced angiogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0302600:Angiogenesis [Organ or Tissue Function]
   799   C1519670:angiogenesis [Neoplastic Process]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "in human cancer cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0334227:cancer cells [Cell]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0007634:Cells [Cell]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.233: Several novel indications have been generated in this study. 

Phrase: "Several novel indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0392360:Indications [Idea or Concept]
   793 E C3146298:Indication [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "generated in this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3146294:Generated [Activity]
Processing 00000000.tx.234: First, the results that ectopic Id-1 expression in LNCaP cells led to the increase in both VEGF protein secretion and its gene promoter activity indicate that upregulation of Id-1 alone in prostate cancer cells activates the VEGF gene expression through transcriptional activation (Figure 1). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "that ectopic Id-1 expression in LNCaP cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1512167:Ectopic Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "led to the increase"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in both VEGF protein secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1159339:Protein Secretion [Cell Function]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "its gene promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "indicate"

Phrase: "that upregulation of Id-1 alone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "in prostate cancer cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the VEGF gene expression through transcriptional activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   782   C0812325:Growth Factor Gene [Gene or Genome]
   760   C0017262:Gene Expression [Genetic Function]
   757   C0017255:Gene Activation [Genetic Function]
   753   C0812327:Transcription Factor Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   722   C0040649:Gene Transcription [Genetic Function]

Phrase: "(Figure 1"

Phrase: ")."
Processing 00000000.tx.235: These results were further confirmed when a Si-Id-1 vector was transfected into DU145 cells that led to the downregulation of Id-1 and VEGF transcription as well as the secretory VEGF protein (Figure 2). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "when"

Phrase: "a Si-Id-1 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "transfected into DU145 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "led to the downregulation of Id-1"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0600091:ID [Intellectual Product]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "VEGF transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0040649:Transcription [Genetic Function]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "as well as"

Phrase: "the secretory VEGF protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   826   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Figure 2"

Phrase: ")."
Processing 00000000.tx.236: Second, the results presented in Figure 3 demonstrated that the secretory VEGF produced by the Id-1 transfectants in the culture medium induced endothelial angiogenesis, indicating that the Id-1-induced VEGF expression is functionally active, which promotes endothelial proliferation and their ability to form new blood vessels. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in Figure 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the secretory VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
   937   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0014257:Endothelial [Tissue]
   804   C0014261:Endothelium, Vascular [Tissue]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C1801960:Vascular [Qualitative Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   776 E C1706972:Blood Vessel Endothelium [Tissue]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "produced by the Id-1 transfectants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0600091:ID [Intellectual Product]

Phrase: "in the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "endothelial angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "indicating"

Phrase: "that"

Phrase: "the Id-1-induced VEGF expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "functionally active,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "which"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "endothelial proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "new blood vessels."
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
   901   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   867 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   867 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   829 E C1558950:VASCULAR [Finding]
   829 E C1801960:Vascular [Qualitative Concept]
   808 E C0005767:Blood [Tissue]
   808 E C0005768:blood [Body Substance]
   808 E C0229664:Blood [Body Substance]
   808 E C0392895:Bloods [Population Group]
   790 E C0333275:Bloody [Qualitative Concept]
   755 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.237: Third, inhibition of VEGF function by the addition of an Flk-1 kinase inhibitor (SU1498) or the VEGF neutralizing antibody blocked the Id-1-induced endothelial proliferation and reduced tube formation ability (Figure 4A), further suggesting that the active VEGF protein secreted by the Id-1 expressing cells is responsible for the stimulatory effect on endothelial cells. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "inhibition of VEGF function"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C1512280:Growth Factor Inhibition [Physiologic Function]
   804   C2249823:inhibition of growth [Organism Function]
   774   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of an Flk-1 kinase inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   861   C3537023:kinase inhibitor [Molecular Function]
   861   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(SU1498"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1436360:SU1498 [Organic Chemical]

Phrase: ")"

Phrase: "or"

Phrase: "the VEGF neutralizing antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   876   C0443907:Endothelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0475463:Neutralising antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the Id-1-induced endothelial proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0334094:Proliferation [Pathologic Function]
   804   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "reduced tube formation ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0085732:Ability [Organism Attribute]
   741 E C1299581:Able [Finding]

Phrase: "(Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the active VEGF protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   826   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "secreted by the Id-1 expressing cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0309276:ID-1 [Pharmacologic Substance]
   748   C0007634:Cells [Cell]
   748   C0600091:ID [Intellectual Product]
   748   C1327616:Secreted [Cell Function]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "responsible for the stimulatory effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "on endothelial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: The results that showed the increased Id-1 expression was associated with the upregulation of VEGF in human xenografts in nude mice (Figure 5) further support the results generated from in vitro cell lines. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the increased Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "associated with the upregulation of VEGF"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   818   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1160196:up-regulation of growth [Organism Function]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0014257:Endothelial [Tissue]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0041904:Up-Regulation [Cell Function,Molecular Function]
   742   C0162493:Up-Regulation [Genetic Function]
   742   C0220844:growth [Physiologic Function]
   742   C1521761:Factor [Functional Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1801960:Vascular [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   729   C0014261:Endothelium, Vascular [Tissue]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]
   701 E C1706972:Blood Vessel Endothelium [Tissue]

Phrase: "in human xenografts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520484:xenografts [Therapeutic or Preventive Procedure]
   861   C0522537:Xenografts [Biomedical or Dental Material]

Phrase: "in nude mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025932:Mice, Nude [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C1425014:NUDE [Gene or Genome]

Phrase: "(Figure 5"

Phrase: ")"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "generated from in vitro cell lines."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0007600:Cell lines [Cell]
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3146294:Generated [Activity]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.239: It is possible that the upregulation of Id-1 in the less aggressive prostate cancer cells may provide an autocrine signal to stimulate the VEGF expression, which is then secreted extracellularly to provide growth factors necessary for the formation of blood vessels for ectopic growth of the cancer cells. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the upregulation of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "in the less aggressive prostate cancer cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0334227:cancer cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an autocrine signal to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "stimulate"

Phrase: "the VEGF expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "extracellularly to"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "necessary for the formation of blood vessels"

Phrase: "for ectopic growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "of the cancer cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0334227:cancer cells [Cell]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0007634:Cells [Cell]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.240: Previously, we have found that Id-1 is upregulated when normal cells progress from hyperplasia to prostate cancer in the animal model (28) and Id-1 expression levels increase with increased Gleason grade in human prostate cancer cells (13). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "is"

Phrase: "upregulated"

Phrase: "when"

Phrase: "normal cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   966   C0007634:Normal cell [Cell]
           Cells
   966   C1268443:Normal cell [Cell]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "progress from hyperplasia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020507:Hyperplasia [Pathologic Function]
   790   C1272688:progress [Functional Concept]
   790   C1280477:Progress [Functional Concept]

Phrase: "to prostate cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]

Phrase: "in the animal model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Animal Model [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Model [Intellectual Product]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "Id-1 expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "increase with increased Gleason grade"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332326:Gleason Grade [Classification]
   760   C0441800:Grade [Classification]
   760   C0442805:Increase [Functional Concept]
   760   C0919553:Grade [Classification]
   760   C3244287:grade [Finding]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "in human prostate cancer cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0334227:cancer cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.241: In addition, ectopic Id-1 expression in the androgen-sensitive LNCaP cells leads to its progression into androgen independent cells (14). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ectopic Id-1 expression in the androgen-sensitive LNCaP cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1512167:Ectopic Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to its progression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "into androgen independent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.242: Recently, it was reported that increased VEGF expression is associated with prostate tumour progression from androgen-dependent to androgen-independent growth in an orthotopic prostate cancer animal model (29). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that increased VEGF expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "associated with prostate tumour progression"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0033578:Prostate Tumor [Neoplastic Process]
   806   C0178874:Tumor Progression [Neoplastic Process]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0027651:Tumor [Neoplastic Process]
   760   C0033572:Prostate [Body Part, Organ, or Organ Component]
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]
   760   C1278980:Prostate [Body Part, Organ, or Organ Component]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "from androgen-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "to androgen-independent growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "in an orthotopic prostate cancer animal model"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1516211:Cancer Model [Experimental Model of Disease]
   840   C0599779:Animal Model [Animal]
   804   C0003062:Animal [Animal]
   804   C3161035:Model [Intellectual Product]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.243: In combination with the evidence presented in this study, these results suggest that the upregulation of Id-1 in prostate cancer may be a key factor not only in promoting prostate carcinogenesis but also in tumour progression. 

Phrase: "In combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "presented in this study,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the upregulation of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "in prostate cancer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "a key factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "not only in promoting prostate carcinogenesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0033414:Promoting [Activity]
   753   C0033572:Prostate [Body Part, Organ, or Organ Component]
   753   C0205171:Only [Quantitative Concept]
   753   C0596263:Carcinogenesis [Neoplastic Process]
   753   C1278980:Prostate [Body Part, Organ, or Organ Component]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "also in tumour progression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178874:Tumor Progression [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
Processing 00000000.tx.244: One of the molecular mechanisms in this process is through the activation of the VEGF gene. 

Phrase: "One of the molecular mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "is through the activation of the VEGF gene."
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   797   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   775   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0812325:Growth Factor Gene [Gene or Genome]
   772   C2249824:activation of growth [Organism Function]
   756   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0017255:Gene Activation [Genetic Function]
   754   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   754   C0314622:Is gene [Gene or Genome]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0014257:Endothelial [Tissue]
   738   C0017337:Gene [Gene or Genome]
   738   C0018270:'growth' NOS [Organism Function]
   738   C0220844:growth [Physiologic Function]
   738   C1521761:Factor [Functional Concept]
   738   C1558950:VASCULAR [Finding]
   738   C1621966:Growth [Organ or Tissue Function]
   738   C1801960:Vascular [Qualitative Concept]
   738   C1879547:Activation [Activity]
   738   C2827422:Factor [Conceptual Entity]
   738   C2911660:Growth [Activity]
   720   C0014261:Endothelium, Vascular [Tissue]
Processing 00000000.tx.245: Recent evidence from studies on breast cancer also supports this hypothesis. 

Phrase: "Recent evidence from studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "on breast cancer also"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0006142:Breast Cancer [Neoplastic Process]
   901   C0678222:Breast Cancer [Neoplastic Process]
   851 E C0153661:thoracic cancer [Neoplastic Process]
   827   C0006141:Breast [Body Part, Organ, or Organ Component]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1268990:Breast [Body Part, Organ, or Organ Component]
   827   C1306459:Cancer [Finding]
   771 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   771 E C1521735:Pectoral [Qualitative Concept]
   743 E C0817096:Chest [Body Location or Region]
   743 E C1527391:Chest [Body Location or Region]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.246: For example, it was reported that ectopic expression of Id-1 in estrogen sensitive breast cancer cells led to reduced estrogen sensitivity (9). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that ectopic expression of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512167:Ectopic Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in estrogen sensitive breast cancer cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   867   C1512505:Breast Cancer Cell [Cell]
   840   C0334227:cancer cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "led to reduced estrogen sensitivity"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   762   C0332324:Sensitive to [Functional Concept]
   760   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
   760   C2936882:Estrogen [Pharmacologic Substance]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.247: By the downregulation of Id-1 using antisense technology, it was possible to prevent the metastasization of breast cancer cells to the lungs of the experimental animals, although the role of Id-1 in angiogenesis was not studied (18). 

Phrase: "By the downregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisense technology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516029:Antisense Technology [Molecular Biology Research Technique]
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "it"

Phrase: "was"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the metastasization of breast cancer cells"

Phrase: "to the lungs"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   966 E C0819757:LUNG [Tissue]
   966 E C1278908:Lung [Body Part, Organ, or Organ Component]
   928 E C2707265:Pulmonary [Clinical Attribute]
   928 E C2709248:Pulmonary [Qualitative Concept]
   900 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "of the experimental animals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003064:experimental animal [Animal]
   861   C0003062:Animals [Animal]
   861   C1517586:Experimental [Qualitative Concept]

Phrase: "although"

Phrase: "the role of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.248: In addition, recently, specific response elements were found in the Id-1 promoter to the bone morphogenic proteins (BMPs) (30), which are frequently upregulated in prostate cancer cells and are important for the formation of bone metastasis (31). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "specific response elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0600508:Response Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Elements [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "were"

Phrase: "found in the Id-1 promoter"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0309276:ID-1 [Pharmacologic Substance]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0150312:Found [Quantitative Concept]
   753   C0600091:ID [Intellectual Product]
   719 E C0243095:Find [Finding]

Phrase: "to the bone morphogenic proteins (BMPs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450131:bone morphogenic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "upregulated in prostate cancer cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C0334227:cancer cells [Cell]
   806   C0376358:Prostate Cancer [Neoplastic Process]
   806   C0600139:Prostate Cancer [Neoplastic Process]
   806   C2984325:Prostate cancer [Functional Concept]
   806   C3541264:Prostate Cancer [Intellectual Product]
   760   C0006826:Cancer [Neoplastic Process]
   760   C0007634:Cells [Cell]
   760   C0033572:Prostate [Body Part, Organ, or Organ Component]
   760   C0998265:Cancer [Eukaryote]
   760   C1278980:Prostate [Body Part, Organ, or Organ Component]
   760   C1306459:Cancer [Finding]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "important for the formation of bone metastasis"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.249: By the treatment of prostate cancer cells with BMPs, it was possible to induce VEGF expression at both transcriptional and protein levels (32). 

Phrase: "By the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of prostate cancer cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]

Phrase: "with BMPs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450131:bone morphogenic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "it"

Phrase: "was"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "VEGF expression at both transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.250: In combination with the results demonstrated in this study, it is possible that in prostate cancer, increased BMP may be able to activate Id-1 through transcriptional activation which in turn stimulates VEGF expression leading to bone metastatic growth. 

Phrase: "In combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrated in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that in prostate cancer,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0376358:Prostate Cancer [Neoplastic Process]
   833   C0600139:Prostate Cancer [Neoplastic Process]
   833   C2984325:Prostate cancer [Functional Concept]
   833   C3541264:Prostate Cancer [Intellectual Product]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0033572:Prostate [Body Part, Organ, or Organ Component]
   770   C0998265:Cancer [Eukaryote]
   770   C1278980:Prostate [Body Part, Organ, or Organ Component]
   770   C1306459:Cancer [Finding]

Phrase: "increased BMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Id-1 through transcriptional activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162493:Transcriptional Activation [Genetic Function]
   806   C0309276:ID-1 [Pharmacologic Substance]
   760   C0040649:Transcriptional [Genetic Function]
   760   C0600091:ID [Intellectual Product]
   760   C1879547:Activation [Activity]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "stimulates"

Phrase: "VEGF expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "leading to bone metastatic growth."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   797   C0036525:Metastatic to [Functional Concept]
           Metastatic
   797   C0971859:Bone Growth [Organ or Tissue Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0332152:Leading [Temporal Concept]
   760   C0391978:Bone [Tissue]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]
   760   C1522484:metastatic [Quantitative Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.251: This hypothesis may also explain why bone metastasis is the common site for the ectopic growth of prostate cancer. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "explain"

Phrase: "why bone metastasis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0153690:Bone Metastasis [Neoplastic Process]
   827   C0027627:Metastasis [Neoplastic Process]
   827   C2939420:metastasis [Neoplastic Process]
   755 E C0036525:Metastatic [Functional Concept]
   755 E C1522484:metastatic [Quantitative Concept]

Phrase: "is"

Phrase: "the common site for the ectopic growth of prostate cancer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0872338:cancer site [Spatial Concept]
   757   C2945843:Site of [Qualitative Concept]
   739   C0205145:Site [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]
Processing 00000000.tx.252: Furthermore, increased Id-1 expression has been associated with advanced tumour stage as well as poor survival in several types of human cancer such as cervical and ovarian cancers (11,33), it is also possible that the positive role of Id-1 in cancer progression and metastasis may not be a specific event in prostate cancer but a general phenotype in human cancer. 

Phrase: "Furthermore,"

Phrase: "increased Id-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "associated with advanced tumour stage"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1300072:Tumor stage [Clinical Attribute]
           Stage
   760   C0027651:Tumor [Neoplastic Process]
   760   C0205179:Advanced [Qualitative Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C1306673:Stage [Qualitative Concept]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "as well as"

Phrase: "poor survival in several types of human cancer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]

Phrase: "such as cervical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027530:Cervical [Body Location or Region]
  1000   C0205064:Cervical [Spatial Concept]

Phrase: "and"

Phrase: "ovarian cancers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancers [Neoplastic Process]
  1000   C1140680:Ovarian Cancers [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "(11,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the positive role of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in cancer progression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0178874:cancer progression [Neoplastic Process]
  1000   C1947901:Cancer Progression [Pathologic Function]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "metastasis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "a specific event in prostate cancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]

Phrase: "but"

Phrase: "a general phenotype in human cancer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.253: However, further studies are necessary to confirm this hypothesis. 

Phrase: "However,"

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "necessary to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.254: In summary, we have demonstrated the positive role of Id-1 in prostate cancer angiogenesis through the activation of VEGF. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "the positive role of Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in prostate cancer angiogenesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1536999:cancer angiogenesis [Neoplastic Process]
   827   C0302600:Angiogenesis [Organ or Tissue Function]
   827   C1519670:angiogenesis [Neoplastic Process]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]

Phrase: "through the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of VEGF."
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.255: Our results not only provide a molecular basis for the function of Id-1 in cancer progression but also suggest a novel therapeutic target in the treatment of androgen-independent metastatic prostate cancer through the inactivation of the Id-1 gene.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a molecular basis for the function of Id-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1853126:MOLECULAR BASIS [Idea or Concept]
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]

Phrase: "in cancer progression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0178874:cancer progression [Neoplastic Process]
  1000   C1947901:Cancer Progression [Pathologic Function]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "but"

Phrase: "also"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a novel therapeutic target in the treatment of androgen-independent metastatic prostate cancer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C1521840:Target [Functional Concept]
   735   C2986546:TARGET [Diagnostic Procedure]

Phrase: "through the inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of the Id-1 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Gene [Gene or Genome]
   734   C0309276:ID-1 [Pharmacologic Substance]
Processing 00000000.tx.256: Supplementary material Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Supplementary material is available online at: http://carcin.oxfordjournals.org/  Notes  These authors contributed equally to this work.  

Phrase: "Supplementary material Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "is"

Phrase: "available online at"

Phrase: ":"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//carcin.oxfordjournals.org/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.257: Acknowledgments  This work was supported by RGC grants to Y.C.Wong (HKU7490/03M) and to X.Wang (HKU7478/03M). 

Phrase: "Acknowledgments"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by RGC grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0018173:Grants [Quantitative Concept]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]
   737 E C1548284:Grant [Idea or Concept]

Phrase: "to Y.C.Wong"

Phrase: "(HKU7490/03M"

Phrase: ")"

Phrase: "and to X.Wang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(HKU7478/03M"

Phrase: ")."
Processing 00000000.tx.258: Conflict of Interest Statement: None declared.  

Phrase: "Conflict of Interest Statement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1710187:Statement [Idea or Concept]
   756   C0079152:Conflict of Interest [Idea or Concept]

Phrase: ":"

Phrase: "None"

Phrase: "declared."
Processing 00000000.tx.259: References Top Abstract Introduction Materials and methods Results Discussion Supplementary material References  Kadesch,T. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion Supplementary material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2936424:Supplementary Material [Intellectual Product]
   804   C0520510:Material [Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Kadesch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.260: (1993) Consequences of heteromeric interactions among helixloophelix proteins. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Consequences of heteromeric interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "among helixloophelix proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.261: Cell Growth Differ., 4, 4955.[ISI][Medline] Ouyang,X.S., Wang,X., Ling,M.T., Wong,H.L., Tsao,S.W. and Wong,Y.C. 

Phrase: "Cell Growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ.,"

Phrase: "4,"

Phrase: "4955."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ouyang,"

Phrase: "X.S.,"

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wong,"

Phrase: "H.L., Tsao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.262: (2002) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "stimulates"

Phrase: "serum independent prostate cancer cell proliferation through inactivation of p16"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0334227:Cancer Cell [Cell]
   760   C0596290:Cell Proliferation [Cell Function]
   739   C0007634:Cell [Cell]
   739   C0334094:Proliferation [Pathologic Function]
   739   C1269647:Cell [Cell]
   739   C1514485:Proliferation [Functional Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "(INK4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0525037:INK4a [Gene or Genome]
  1000   C1705280:INK4A [Gene or Genome]

Phrase: ")"

Phrase: "/pRB pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.263: Carcinogenesis, 23, 721725.[Abstract/Free FullText] Kreider,B.L., Benezra,R., Rovera,G. and Kadesch,T. 

Phrase: "Carcinogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "721725."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kreider,"

Phrase: "B.L., Benezra,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rovera,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kadesch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.264: (1992) Inhibition of myeloid differentiation by the helixloophelix protein Id. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Inhibition of myeloid differentiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by the helixloophelix protein Id."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600091:ID [Intellectual Product]
Processing 00000000.tx.265: Science, 255, 17001702.[ISI][Medline] Alani,R.M., Hasskarl,J., Grace,M., Hernandez,M.C., Israel,M.A. and Munger,K. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "255,"

Phrase: "17001702."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Hasskarl,"

Phrase: "J.,"

Phrase: "Grace,"

Phrase: "M."

Phrase: ","

Phrase: "Hernandez,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Munger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.266: (1999) Immortalization of primary human keratinocytes by the helixloophelix protein, Id-1. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immortalization of primary human keratinocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2826170:Immortalization [Molecular Biology Research Technique]

Phrase: "by the helixloophelix protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Id-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]
Processing 00000000.tx.267: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.268: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.269: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.270: USA, 96, 96379641.[Abstract/Free FullText] Nickoloff,B.J., Chaturvedi,V., Bacon,P., Qin,J.Z., Denning,M.F. and Diaz,M.O. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "96,"

Phrase: "96379641."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nickoloff,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Chaturvedi,"

Phrase: "V.,"

Phrase: "Bacon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052889:BACON [Therapeutic or Preventive Procedure]
  1000   C0452861:Bacon [Food]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "J.Z.,"

Phrase: "Denning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178587:DEN [Quantitative Concept]

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Diaz,"

Phrase: "M.O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.271: (2000) Id-1 delays senescence but does not immortalize keratinocytes. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309276:ID-1 [Pharmacologic Substance]
   861   C0600091:ID [Intellectual Product]

Phrase: "delays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "senescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231337:Senescence [Finding]
  1000   C1999167:Senescence [Population Group]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "immortalize"

Phrase: "keratinocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022567:Keratinocytes [Cell]
Processing 00000000.tx.272: J. 

Phrase: "J."
Processing 00000000.tx.273: Biol. 

Phrase: "Biol."
Processing 00000000.tx.274: Chem., 275, 2750127504.[Abstract/Free FullText] Ohtani,N., Zebedee,Z., Huot,T.J., Stinson,J.A., Sugimoto,M., Ohashi,Y., Sharrocks,A.D., Peters,G. and Hara,E. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "2750127504."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohtani,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Zebedee,"

Phrase: "Z.,"

Phrase: "Huot,"

Phrase: "T.J.,"

Phrase: "Stinson,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Sugimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Ohashi,"

Phrase: "Y.,"

Phrase: "Sharrocks,"

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Peters,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "E."
Processing 00000000.tx.275: (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Opposing effects of Ets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Id proteins on p16INK4a expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0249880:p16INK4A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1171362:expression protein [Genetic Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "during cellular senescence."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007581:Senescence, Cellular [Cell Function]
   861   C0231337:Senescence [Finding]
   861   C1999167:Senescence [Population Group]
Processing 00000000.tx.276: Nature, 409, 10671070.[CrossRef][ISI][Medline] Wong,Y.C., Wang,X. and Ling,M.T. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "409,"

Phrase: "10671070."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wong,"

Phrase: "Y.C., Wang,"

Phrase: "X."

Phrase: "and"

Phrase: "Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.277: (2004) Id-1 expression and cell survival. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "and"

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: Apoptosis, 9, 279289.[CrossRef][ISI][Medline] Ling,M.T., Wang,X., Ouyang,X.S., Xu,K., Tsao,S.W. and Wong,Y.C. 

Phrase: "Apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "9,"

Phrase: "279289."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Ouyang,"

Phrase: "X.S.,"

Phrase: "Xu,K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.279: (2003) Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell survival through activation of NF-kappaB signalling pathway"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0007620:Cell Survival [Cell Function]
   762   C1326120:cell activation [Cell Function]
   745   C0037083:signal cell [Cell Function]
   742   C0007634:Cell [Cell]
   742   C0038952:Survival [Activity]
   742   C0220921:survival [Functional Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "in prostate cancer cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]
Processing 00000000.tx.280: Oncogene, 22, 44984508.[CrossRef][ISI][Medline] Lin,C.Q., Singh,J., Murata,K., Itahana,Y., Parrinello,S., Liang,S.H., Gillett,C.E., Campisi,J. and Desprez,P.Y. 

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "22,"

Phrase: "44984508."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lin,C.Q., Singh,"

Phrase: "J.,"

Phrase: "Murata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Itahana,"

Phrase: "Y.,"

Phrase: "Parrinello,"

Phrase: "S."

Phrase: ","

Phrase: "Liang,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gillett,"

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Campisi,"

Phrase: "J."

Phrase: "and"

Phrase: "Desprez,"

Phrase: "P.Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.281: (2000) A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A role for Id-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the aggressive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "steroid hormone response of human breast cancer cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
Processing 00000000.tx.282: Cancer Res., 60, 13321340.[Abstract/Free FullText] Takai,N., Miyazaki,T., Fujisawa,K., Nasu,K. and Miyakawa,I. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "60,"

Phrase: "13321340."

Phrase: "[Abstract/Free FullText"

Phrase: "] Takai,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fujisawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331815:Fujisawa [Health Care Related Organization]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nasu,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Miyakawa,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.283: (2001) Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Id1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "associated with histological grade"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0456201:Histological grade [Classification]
   797 E C1317415:Histology grade [Classification]
   783 E C0919553:Histologic grade [Classification]
           Grade
   770   C0205462:Histological [Functional Concept]
   770   C0441800:Grade [Classification]
   770   C3244287:grade [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "invasive behavior in endometrial carcinoma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004927:Behavior [Individual Behavior]
   760   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.284: Cancer Lett., 165, 185193.[CrossRef][ISI][Medline] Schindl,M., Oberhuber,G., Obermair,A., Schoppmann,S.F., Karner,B. and Birner,P. 

Phrase: "Cancer Lett.,"

Phrase: "165,"

Phrase: "185193."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Oberhuber,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Obermair,"

Phrase: "A.,"

Phrase: "Schoppmann,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Karner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Birner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.285: (2001) Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Overexpression of Id-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "is"

Phrase: "a marker for unfavorable prognosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514475:Prognosis Marker [Qualitative Concept]
   760   C0005516:Marker [Clinical Attribute]

Phrase: "in early-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "cervical cancer."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007847:Cervical Cancer [Neoplastic Process]
  1000   C0302592:Cervical Cancer [Neoplastic Process]
  1000   C3539064:Cervical Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0027530:Cervical [Body Location or Region]
   861   C0205064:Cervical [Spatial Concept]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.286: Cancer Res., 61, 57035706.[Abstract/Free FullText] Schoppmann,S.F., Schindl,M., Bayer,G., Aumayr,K., Dienes,J., Horvat,R., Rudas,M., Gnant,M., Jakesz,R. and Birner,P. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "61,"

Phrase: "57035706."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schoppmann,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Bayer,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aumayr,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dienes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596439:dienes [Organic Chemical]

Phrase: "J.,"

Phrase: "Horvat,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rudas,"

Phrase: "M."

Phrase: ","

Phrase: "Gnant,"

Phrase: "M."

Phrase: ","

Phrase: "Jakesz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Birner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.287: (2003) Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Overexpression of Id-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "associated with poor clinical outcome"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0032854:Poor [Group Attribute]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0542537:Poor [Qualitative Concept]
   760   C1274040:Outcome [Functional Concept]
   760   C2700379:Poor [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in node negative breast cancer."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   861   C0006142:Breast Cancer [Neoplastic Process]
   861   C0678222:Breast Cancer [Neoplastic Process]
   812   C0006141:Breast [Body Part, Organ, or Organ Component]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1268990:Breast [Body Part, Organ, or Organ Component]
   812   C1306459:Cancer [Finding]
   811 E C0153661:thoracic cancer [Neoplastic Process]
   756 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   756 E C1521735:Pectoral [Qualitative Concept]
   729 E C0817096:Chest [Body Location or Region]
   729 E C1527391:Chest [Body Location or Region]
Processing 00000000.tx.288: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: Cancer, 104, 677682.[CrossRef][ISI][Medline] Ouyang,X.S., Wang,X., Lee,D.T., Tsao,S.W. and Wong,Y.C. 

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "104,"

Phrase: "677682."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ouyang,"

Phrase: "X.S.,"

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Lee,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.291: (2002) Over expression of ID-1 in prostate cancer. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Over expression of ID-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205136:Over [Spatial Concept]

Phrase: "in prostate cancer."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0376358:Prostate Cancer [Neoplastic Process]
  1000   C0600139:Prostate Cancer [Neoplastic Process]
  1000   C2984325:Prostate cancer [Functional Concept]
  1000   C3541264:Prostate Cancer [Intellectual Product]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.292: J. 

Phrase: "J."
Processing 00000000.tx.293: Urol., 167, 25982602.[CrossRef][ISI][Medline] Ling,M.T., Wang,X., Lee,D.T., Tam,P.C., Tsao,S.W. and Wong,Y.C. 

Phrase: "Urol.,"

Phrase: "167,"

Phrase: "25982602."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Lee,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tam,P.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039286:TAM [Organic Chemical,Pharmacologic Substance]
   827   C0410207:TAM [Disease or Syndrome]
   827   C1834582:TAM [Neoplastic Process]

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.294: (2004) Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). 

Phrase: "(2004"

Phrase: ")"

Phrase: "Id-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0309276:ID-1 [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "androgen-independent prostate cancer cell growth through activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1516170:Cancer Cell Growth [Neoplastic Process]
   770   C0007595:Cell Growth [Cell Function]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]

Phrase: "of epidermal growth factor receptor (EGF-R)."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
Processing 00000000.tx.295: Carcinogenesis, 25, 517525.[Abstract/Free FullText] Ling,M.T., Wang,X., Ouyang,X.S., Lee,T.K., Fan,T.Y., Xu,K., Tsao,S.W. and Wong,Y.C. 

Phrase: "Carcinogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: "25,"

Phrase: "517525."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Ouyang,"

Phrase: "X.S.,"

Phrase: "Lee,"

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441039:Fan [Manufactured Object]
  1000   C1705854:Fan [Manufactured Object]
  1000   C3540815:FAN [Gene or Genome]

Phrase: "T.Y.,"

Phrase: "Xu,K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.296: (2002) Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Activation of MAPK signaling pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1819041:protein kinase activation [Cell Function]
   789   C1514528:Protein Activation Pathway [Functional Concept]
   789   C3156336:protein activation pathway [Molecular Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "essential for Id-1 induced serum independent prostate cancer cell growth."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.297: Oncogene, 21, 84988505.[CrossRef][ISI][Medline] Lyden,D., Young,A.Z., Zagzag,D. et al. 

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "21,"

Phrase: "84988505."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lyden,"

Phrase: "D."

Phrase: ","

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "A.Z.,"

Phrase: "Zagzag,"

Phrase: "D. et al."
Processing 00000000.tx.298: (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "are"

Phrase: "required for neurogenesis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0814002:Neurogenesis [Cell Function,Organism Function]
   790   C1514873:Required [Functional Concept]
   718 E C0597047:neurogenetic [Biomedical Occupation or Discipline]

Phrase: "angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "vascularization of tumour xenografts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027686:Vascularisation [Pathologic Function]
   770   C0042382:Vascularisation [Functional Concept]
Processing 00000000.tx.299: Nature, 401, 670677.[CrossRef][ISI][Medline] Ruzinova,M.B., Schoer,R.A., Gerald,W., Egan,J.E., Pandolfi,P.P., Rafii,S., Manova,K., Mittal,V. and Benezra,R. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "401,"

Phrase: "670677."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ruzinova,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schoer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Gerald,"

Phrase: "W.,"

Phrase: "Egan,"

Phrase: "J.E.,"

Phrase: "Pandolfi,"

Phrase: "P.P.,"

Phrase: "Rafii,"

Phrase: "S."

Phrase: ","

Phrase: "Manova,K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mittal,"

Phrase: "V."

Phrase: "and"

Phrase: "Benezra,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.300: (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Effect of angiogenesis inhibition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C3179307:Angiogenesis Effect [Physiologic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
   715   C1510884:inhibition of angiogenesis [Cell Function]

Phrase: "by Id loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "the contribution of bone-marrow-derived endothelial cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "in spontaneous murine tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]
Processing 00000000.tx.301: Cancer Cell, 4, 277289.[CrossRef][ISI][Medline] Fong,S., Itahana,Y., Sumida,T. et al. 

Phrase: "Cancer Cell,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0334227:Cancer Cell [Cell]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0007634:Cell [Cell]
   861   C0998265:Cancer [Eukaryote]
   861   C1269647:Cell [Cell]
   861   C1306459:Cancer [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "4,"

Phrase: "277289."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3280437:FONG [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Itahana,"

Phrase: "Y.,"

Phrase: "Sumida,"

Phrase: "T. et al."
Processing 00000000.tx.302: (2003) Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Id-1 as a molecular target"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0309276:ID-1 [Pharmacologic Substance]
   790   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   753   C0600091:ID [Intellectual Product]
   753   C1521840:Target [Functional Concept]
   753   C1521991:Molecular [Qualitative Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "for breast cancer cell invasion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C2699153:Cell Invasion [Pathologic Function]
           Invasion
   812   C1269955:Invasion [Finding]
   756   C1512505:Breast Cancer Cell [Cell]

Phrase: "and"

Phrase: "metastasis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.303: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.304: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.305: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.306: USA, 100, 1354313548.[Abstract/Free FullText] Denmeade,S.R. and Isaacs,J.T. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "1354313548."

Phrase: "[Abstract/Free FullText"

Phrase: "] Denmeade,"

Phrase: "S.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Isaacs,"

Phrase: "J.T."
Processing 00000000.tx.307: (2004) Development of prostate cancer treatment: the good news. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Development of prostate cancer treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1326669:prostate development [Organ or Tissue Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: ":"

Phrase: "the good news."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282425:News [Intellectual Product]
Processing 00000000.tx.308: Prostate, 58, 211224.[CrossRef][ISI][Medline] Dowling,A.J. and Tannock,I.F. 

Phrase: "Prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "58,"

Phrase: "211224."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dowling,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "Tannock,"

Phrase: "I.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.309: (1998) Systemic treatment for prostate cancer. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Systemic treatment for prostate cancer."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0920425:Cancer Treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.310: Cancer Treat. 

Phrase: "Cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "Treat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]
Processing 00000000.tx.311: Rev., 24, 283301.[CrossRef][ISI][Medline] Berse,B., Brown,L.F., Van de,W.L., Dvorak,H.F. and Senger,D.R. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "24,"

Phrase: "283301."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Berse,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "L.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Van de,W.L., Dvorak,"

Phrase: "H.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Senger,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.312: (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Vascular permeability factor"
Meta Candidates (Total=19; Excluded=8; Pruned=0; Remaining=11)
  1000   C0078058:Vascular Permeability Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1171892:vascular permeability factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522575:Vascular Permeability Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   901   C0162337:Vascular Permeability [Organ or Tissue Function]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C1521761:Factor [Functional Concept]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   827   C2827422:Factor [Conceptual Entity]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0205326:Permeable [Functional Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "(vascular endothelial growth factor"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "expressed"

Phrase: "differentially in normal tissues,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   816   C0040300:Normal Tissue [Tissue]
           Tissues
   816   C0332441:Normal tissue [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "macrophages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "and"

Phrase: "tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]
Processing 00000000.tx.313: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.314: Biol. 

Phrase: "Biol."
Processing 00000000.tx.315: Cell, 3, 211220.[Abstract] Li,Z., Wang,D., Na,X., Schoen,S.R., Messing,E.M. and Wu,G. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "211220."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Li,Z.,"

Phrase: "Wang,"

Phrase: "D."

Phrase: ","

Phrase: "Na,X.,"

Phrase: "Schoen,"

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Messing,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Wu,G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.316: (2003) The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The VHL protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299505:VHL Protein [Amino Acid, Peptide, or Protein,Enzyme]
           VHL
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0694897:VHL [Gene or Genome]

Phrase: "recruits"

Phrase: "a novel KRAB-"

Phrase: "A domain protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "repress"

Phrase: "HIF-1alpha transcriptional activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.317: EMBO J., 22, 18571867.[Abstract/Free FullText] Wang,X., Jin,D.Y., Ng,R.W., Feng,H., Wong,Y.C., Cheung,A.L. and Tsao,S.W. 

Phrase: "EMBO J.,"

Phrase: "22,"

Phrase: "18571867."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "X.,"

Phrase: "Jin,"

Phrase: "D."

Phrase: "Y.,"

Phrase: "Ng,R.W., Feng,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wong,"

Phrase: "Y.C., Cheung,"

Phrase: "A.L."

Phrase: "and"

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.318: (2002) Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Significance of MAD2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "to mitotic checkpoint control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C1155748:Mitotic Checkpoint [Cell Function]

Phrase: "in ovarian cancer cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0334227:cancer cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0029925:ovarian cancer [Neoplastic Process]
   734   C1140680:Ovarian Cancer [Neoplastic Process]
Processing 00000000.tx.319: Cancer Res., 62, 16621668.[Abstract/Free FullText] Nagabhushan,M., Miller,C.M., Pretlow,T.P. et al. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "62,"

Phrase: "16621668."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nagabhushan,"

Phrase: "M."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Pretlow,"

Phrase: "T.P. et al."
Processing 00000000.tx.320: (1996) CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. 

Phrase: "(1996"

Phrase: ")"

Phrase: "CWR22"

Phrase: ":"

Phrase: "the first human prostate cancer xenograft with strongly androgen-dependent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0520484:xenograft [Therapeutic or Preventive Procedure]
   739   C0522537:Xenograft [Biomedical or Dental Material]

Phrase: "and"

Phrase: "relapsed strains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and in soft agar."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001771:Agar [Carbohydrate,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0205358:Soft [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C3542022:SOFT [Disease or Syndrome]
Processing 00000000.tx.321: Cancer Res., 56, 30423046.[Abstract] Chen,C.T., Gan,Y., Au,J.L. and Wientjes,M.G. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "56,"

Phrase: "30423046."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "C.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Gan,Y.,"

Phrase: "Au,J.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0475218:AU/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wientjes,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.322: (1998) Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Androgen-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and -"

Phrase: "independent human prostate xenograft tumors as models"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C0033578:prostate tumors [Neoplastic Process]
   748   C0027651:Tumors [Neoplastic Process]
   741   C1710493:Tumor Model [Intellectual Product]
   714 E C1578706:Tumor [Intellectual Product]
   714 E C3273930:Tumor [Finding]

Phrase: "for drug activity evaluation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0013175:Drug Evaluation [Research Activity]
   827   C0220825:Evaluation [Functional Concept]
   827   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.323: Cancer Res., 58, 27772783.[Abstract] Harper,M.E., Glynne Jones,E., Goddard,L., Thurston,V.J. and Griffiths,K. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "58,"

Phrase: "27772783."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Harper,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Glynne Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "E.,"

Phrase: "Goddard,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Thurston,"

Phrase: "V.J."

Phrase: "and"

Phrase: "Griffiths,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.324: (1996) Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Vascular endothelial growth factor"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "(VEGF"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ")"

Phrase: "expression in prostatic tumours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its relationship to neuroendocrine cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.325: Br. 

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.326: J. 

Phrase: "J."
Processing 00000000.tx.327: Cancer, 74, 910916.[ISI][Medline] Li,H., Gerald,W.L. and Benezra,R. 

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "74,"

Phrase: "910916."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gerald,"

Phrase: "W.L."

Phrase: "and"

Phrase: "Benezra,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: (2004) Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Utilization of bone marrow-derived endothelial cell precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0042153:utilization [Functional Concept]

Phrase: "in spontaneous prostate tumors"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0033578:prostate tumors [Neoplastic Process]
   827   C0027651:Tumors [Neoplastic Process]
   793 E C1578706:Tumor [Intellectual Product]
   793 E C3273930:Tumor [Finding]

Phrase: "varies with tumor grade."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0441800:Grade [Classification]
   770   C0919553:Grade [Classification]
   770   C1548673:Varies [Intellectual Product]
   770   C1578706:Tumor [Intellectual Product]
   770   C3244287:grade [Finding]
   770   C3273930:Tumor [Finding]
Processing 00000000.tx.329: Cancer Res., 64, 61376143.[Abstract/Free FullText] Ouyang,X.S., Wang,X., Lee,D.T., Tsao,S.W. and Wong,Y.C. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "64,"

Phrase: "61376143."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ouyang,"

Phrase: "X.S.,"

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "Lee,"

Phrase: "D.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tsao,"

Phrase: "S.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wong,"

Phrase: "Y.C."
Processing 00000000.tx.330: (2001) Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Up-regulation of TRPM-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "MMP-7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0166059:MMP-7 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417212:MMP7 [Gene or Genome]
  1000   C2698026:MMP7 [Laboratory Procedure]
  1000   C3273828:MMP-7 [Gene or Genome]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "ID-1 during sex hormone-induced prostate carcinogenesis"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0036884:Sex hormone [Hormone,Pharmacologic Substance]
   770   C0309276:ID-1 [Pharmacologic Substance]
   744   C0009253:Sex [Organism Function]
   744   C0019932:Hormone [Hormone]
   744   C0033572:Prostate [Body Part, Organ, or Organ Component]
   744   C0036864:Sex [Behavior]
   744   C0079399:sex [Organism Attribute]
   744   C0205263:Induced [Functional Concept]
   744   C0596263:Carcinogenesis [Neoplastic Process]
   744   C0600091:ID [Intellectual Product]
   744   C1278980:Prostate [Body Part, Organ, or Organ Component]
   744   C1314687:Sex [Finding]
   744   C1522384:sex [Organism Attribute]
   731   C1512491:Hormonal Carcinogenesis [Biomedical Occupation or Discipline]

Phrase: "in the Noble rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
Processing 00000000.tx.331: Carcinogenesis, 22, 965973.[Abstract/Free FullText] Zhou,J.R., Yu,L., Zerbini,L.F., Libermann,T.A. and Blackburn,G.L. 

Phrase: "Carcinogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596263:Carcinogenesis [Neoplastic Process]

Phrase: "22,"

Phrase: "965973."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhou,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zerbini,"

Phrase: "L.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Libermann,"

Phrase: "T.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Blackburn,"

Phrase: "G.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439294:g l [Quantitative Concept]
Processing 00000000.tx.332: (2004) Progression to androgen-independent LNCaP human prostate tumors: cellular and molecular alterations. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Progression to androgen-independent LNCaP human prostate tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0178874:Tumor Progression [Neoplastic Process]
   744   C0242656:progression [Pathologic Function]
   744   C0449258:Progression [Functional Concept]

Phrase: ":"

Phrase: "cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular alterations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.333: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.334: J. 

Phrase: "J."
Processing 00000000.tx.335: Cancer, 110, 800806.[CrossRef][ISI][Medline] Korchynskyi,O. and ten Dijke,P. 

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "110,"

Phrase: "800806."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Korchynskyi,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "ten Dijke,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014518:TEN [Disease or Syndrome]
   861   C0205456:Ten [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.336: (2002) Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "functional characterization of distinct critically important bone morphogenetic protein-specific response elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "in the Id1 promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.337: J. 

Phrase: "J."
Processing 00000000.tx.338: Biol. 

Phrase: "Biol."
Processing 00000000.tx.339: Chem., 277, 48834891.[Abstract/Free FullText] Bentley,H., Hamdy,F.C., Hart,K.A., Seid,J.M., Williams,J.L., Johnstone,D. and Russell,R.G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "48834891."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bentley,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hamdy,"

Phrase: "F.C., Hart,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Seid,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Williams,"

Phrase: "J.L., Johnstone,"

Phrase: "D."

Phrase: "and"

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.340: (1992) Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Expression of bone morphogenetic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human prostatic adenocarcinoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007112:prostatic adenocarcinoma [Neoplastic Process]
   827   C0001418:Adenocarcinoma [Neoplastic Process]
   827   C0033572:Prostatic [Body Part, Organ, or Organ Component]
   827   C1522721:Prostatic [Spatial Concept]

Phrase: "and"

Phrase: "benign prostatic hyperplasia."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0005001:benign prostatic hyperplasia [Pathologic Function]
           prostatic hyperplasia
  1000   C1704272:Benign Prostatic Hyperplasia [Neoplastic Process]
  1000   C2937421:benign prostatic hyperplasia [Disease or Syndrome]
           Prostatic Hyperplasia
   827   C0020507:Hyperplasia [Pathologic Function]
   827   C0033572:Prostatic [Body Part, Organ, or Organ Component]
   827   C0205183:Benign [Qualitative Concept]
   827   C1522721:Prostatic [Spatial Concept]
Processing 00000000.tx.341: Br. 

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.342: J. 

Phrase: "J."
Processing 00000000.tx.343: Cancer, 66, 11591163.[ISI][Medline] Dai,J., Kitagawa,Y., Zhang,J., Yao,Z., Mizokami,A., Cheng,S., Nor,J., McCauley,L.K., Taichman,R.S. and Keller,E.T. 

Phrase: "Cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "66,"

Phrase: "11591163."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dai,J.,"

Phrase: "Kitagawa,"

Phrase: "Y.,"

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "Yao,"

Phrase: "Z.,"

Phrase: "Mizokami,"

Phrase: "A.,"

Phrase: "Cheng,"

Phrase: "S."

Phrase: ","

Phrase: "Nor,J.,"

Phrase: "McCauley,"

Phrase: "L.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Taichman,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Keller,"

Phrase: "E.T."
Processing 00000000.tx.344: (2004) Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Vascular endothelial growth factor"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
  1000   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C0014261:Endothelium, Vascular [Tissue]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C1801960:Vascular [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   797 E C1706972:Blood Vessel Endothelium [Tissue]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "contributes to the prostate cancer-induced osteoblast differentiation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   770   C0376358:Prostate Cancer [Neoplastic Process]
   770   C0600139:Prostate Cancer [Neoplastic Process]
   770   C1159974:osteoblast differentiation [Cell Function]
   770   C2984325:Prostate cancer [Functional Concept]
   770   C3541264:Prostate Cancer [Intellectual Product]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0007589:Differentiation [Cell Function]
   744   C0029418:Osteoblast [Cell]
   744   C0033572:Prostate [Body Part, Organ, or Organ Component]
   744   C0205263:Induced [Functional Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1278980:Prostate [Body Part, Organ, or Organ Component]
   744   C1306459:Cancer [Finding]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1880177:Contribute [Activity]
   744   C2945687:Differentiation [Functional Concept]

Phrase: "mediated by bone morphogenetic protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0053932:Bone Morphogenetic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2610491:bone morphogenesis [Organism Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0391978:Bone [Tissue]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]
Processing 00000000.tx.345: Cancer Res., 64, 994999.[Abstract/Free FullText] Schindl,M., Schoppmann,S.F., Strobel,T., Heinzl,H., Leisser,C., Horvat,R. and Birner,P. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "64,"

Phrase: "994999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schindl,"

Phrase: "M."

Phrase: ","

Phrase: "Schoppmann,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Strobel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Heinzl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leisser,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Horvat,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Birner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.346: (2003) Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Level of Id-1 protein expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0428479:Protein level [Laboratory or Test Result]
   783   C0456947:Level 1 [Intellectual Product]
   783   C3244092:expression level [Idea or Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "correlates with poor differentiation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007589:Differentiation [Cell Function]
   770   C0032854:Poor [Group Attribute]
   770   C0542537:Poor [Qualitative Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2700379:Poor [Qualitative Concept]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "malignant potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "more aggressive clinical behavior of epithelial ovarian tumors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C0475436:Behavior of tumor [Functional Concept]
   767   C0001807:Aggressive behavior [Mental or Behavioral Dysfunction]
   744   C0004927:Behavior [Individual Behavior]
   744   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.347: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.348: Cancer Res., 9, 779785.[Abstract/Free FullText] Received November 24, 2004; 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "9,"

Phrase: "779785."

Phrase: "[Abstract/Free FullText"

Phrase: "] Received November 24,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.349: revised May 3, 2005; 

Phrase: "revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "May 3,"

Phrase: "2005"

Phrase: ";"
Processing 00000000.tx.350: accepted May 13, 2005. 

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "May 13,"

Phrase: "2005."
Processing 00000000.tx.351: This Article Abstract Full Text (PDF) Supplementary Material All Versions of this Article: 26/10/1668 most recent bgi128v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Request Permissions Google Scholar Articles by Ling, M.-T. 

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF) Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "26/10/1668 most recent bgi128v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Ling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452995:Ling [Food]
  1000   C3486754:LING [Pharmacologic Substance]

Phrase: "M.-T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.352: Articles by Wong, Y.-C. 

Phrase: "Articles by Wong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "Y.-C."
Processing 00000000.tx.353: PubMed PubMed Citation Articles by Ling, M.-T. 

Phrase: "PubMed PubMed Citation Articles by Ling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "M.-T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: Articles by Wong, Y.-C. 

Phrase: "Articles by Wong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "Y.-C."
Processing 00000000.tx.355: Online ISSN 1460-2180 - Print ISSN 0143-3334 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2180 - Print ISSN 0143-3334 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

